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Abstract 
Rats produce ultrasonic vocalizations that can be categorized into two types of ultrasonic 
calls based on their sonographic structure. One group contains 22-kHz ultrasonic vocalization 
(USVs), characterized by relatively constant (flat) frequency with peak frequency ranging from 
19 to 28-kHz, and a call duration ranging between 100 – 3000 ms. These vocalization can be 
induced by cholinomimetic agents injected into the ascending mesolimbic cholinergic system 
that terminates in the anterior hypothalamic-preoptic area (AH-MPO) and lateral septum (LS). 
The other group of USVs contains 50-kHz USVs, characterized by high peak frequency, ranging 
from 39 to 90-kHz, short duration ranging from 10-90 ms, and varying frequency and complex 
sonographic morphology. These vocalizations can be induced by dopaminergic agents injected 
into the nucleus accumbens, the target area for the mesolimbic dopaminergic system. 22-kHz 
USVs are emitted in situations that are highly aversive, such as proximity of a predator or 
anticipation of a foot shock, while 50 kHz USVs are emitted in rewarding and appetitive 
situations, such as juvenile play behaviour or anticipation of rewarding electrical brain 
stimulation. The activities of these two mesolimbic systems were postulated to be antagonistic to 
each other. The current thesis is focused on the interaction of these systems indexed by emission 
of relevant USVs. It was hypothesized that emission of 22 kHz USVs will be antagonized by 
prior activation of the dopaminergic system while emission of 50 kHz will be antagonized by 
prior activation of the cholinergic system. It was found that injection of apomorphine into the 
shell of the nucleus accumbens significantly decreased the number of carbachol-induced 22 kHz 
USVs from both AH-MPO and LS. Injection of carbachol into the LS significantly decreased the 
number of apomorphine-induced 50 kHz USVs from the shell of the nucleus accumbens. The 
results of the study supported the main hypotheses that the mesolimbic dopaminergic and 
cholinergic systems function in antagonism to each other.  
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Introduction 
Emotions 
Emotions are internal states that allow an animal to regulate and maintain motivational 
behaviours when interacting within the environment (Griffiths, 2001; Rolls, 2001). Emotions 
help preserve arousal and motivational states that are involved in the procurement of food, water 
and essential nutrients that help maintain an internal homeostasis. Emotions also help preserve 
complex motivational states and help animals navigate complex social interactions within a 
group or a colony (Rolls, 2001). Regulating an animal’s interaction within the social 
environment is dependent on the ability to communicate a variety of different emotionally-
related signals to group members. The method of communication has evolved concurrently with 
the complexity of the social group allowing for the optimization of signal transmission.  
Communication by animals involves two components. The first component in the act of 
communicating involves the propagation of a signal which has been converted into a sign. The 
sign that has been encrypted contains the semiotic content that is associated with the “message”, 
which has to be decoded by the brain of the receiver (Brudzynski, 2005). Once the receiver has 
decoded and interpreted the sign the semiotic content has the ability to alter the behaviour or 
physiological processes of the receiver. An example of such a relationship between the sender 
and the receiver is demonstrated in a number of mammalian species. For example, Vervet 
monkeys have evolved different signs that communicate information signaling the location of 
aerial predators and different signs that communicate information signaling terrestrial predators, 
such as leopards and snakes (Seyfarth et al, 1980). The different alarm calls initiate different 
behaviours in monkeys. Terrestrial alarm calls alerting group members to a snake or leopard 
cause the monkeys to run up trees, while aerial alarm calls cause the monkeys to run into dense 
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brush and/or look to the sky (Seryfarth et al, 1980). Similarly, salamanders and fishes have 
sophisticated chemical signals to signal species-typical mating cues (Ptacek, 2000) to attract 
mates. Although many forms of communication exist between the signaler and the receiver, one 
of the most prolific forms of communication in mammals is by means of vocalization 
(Brudzynski, 2005; 2007). Vocalization (or acoustic communication) offers distinct advantages 
over other forms of communication like chemical signaling or visual signaling. Vocal 
communication is not dependent upon light, is not dependent upon proximity of conspecifics, the 
pitch, duration and frequency of vocal communication can encode robust messages and vocal 
communication can be terminated immediately.   
Vocal Communication in mammals 
Vocal communication is produced by pressurized air released through vibrating focal 
folds in the larynx. The power of the produced sound thus depends on the lung pressure, the 
aperture of the vocal folds and the frequency in which the vocal folds vibrate (Fletcher, 2010). 
As the pressure wave propagates away from the source, it is subjected to multiple environmental 
conditions such as energy absorption by the air, ground impedance and absorption/reflection by 
various environmental objects (Fletcher, 2010). This makes the source of the vocalization 
difficult to localize by predators and allows signs to be communicated without being dependent 
upon visibility between the sender and the receiver. Vocal communication also allows for the 
transmission of information to be independent of the availability of light.  The ability to 
communicate in the absence of being visible is an adaptive advantage in rodents who are prey for 
a variety of different carnivores that hunt in the day and night (Brudzynski, 2005; Brudzynski 
and Fletcher, 2010).  
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Communication in rats 
Both audible vocalization and ultrasonic vocalization (USVs) in rats communicate 
semiotic information that contains several adaptive values. Audible vocalizations refer to 
vocalizations that are emitted by rats that have a frequency range of 2-4 kHz (Brudzynski, 2007). 
Audible vocalizations in rats can be emitted under situation of physical pain (Borszcz, 2006) or 
under situations where physical pain is anticipated. Audible vocalizations in rats can also be 
emitted in response to approaching predators signaling that the rat is ready for defensive attacks 
(Litvin et al. 2007). 
 Vocalizations in rats that have a frequency range from 19 to 100- kHz are called 
ultrasonic vocalizations (USVs). USVs can be quantified by their peak frequency which is 
measured in kHz, their duration which is measured in milliseconds (ms), their bandwidth which 
is the difference between the maximum and minimum frequency of the call, and by their 
structural morphology (Brudzynski, 2007). USVs emitted by rats ranging from 19- to 100-kHz 
are classified into two different forms of USVs. One type of USVs is termed defensive-based 22-
kHz USVs and is quantified as having a peak frequency between 19- to 32-kHz, a duration that 
ranges from 100 – 3000 ms and a consistently flat bandwidth (Bihari et al, 2003). The second 
form of USVs is categorized as 50-kHz USVs and they are quantified by their peak frequencies 
ranging from 45- to 90-kHz, there relatively short durations which range from 10 – 90 ms, and 
their highly variable bandwidth (Burgdorf, 2000; 2001). The production of USVs that have 
parameters that fall within the range of 22-kHz are able to index the signalers negative-emotional 
state since these vocalizations are produced in punishing circumstances. The production of USVs 
that have parameters which fall within the range of 50-kHz USVs are able to index the signalers 
positive-emotional state since these vocalizations are producing during positive pro-social 
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circumstances. Both forms of USVs have adaptive values and are important for the survival of 
the animal and thus, remain mutually antagonoistic to each other in order to preserve the sign 
being communicated.  
Evidence that supports the idea that 22-kHz USVs are defensive alarm calls that index a 
negative-emotional state in the signaler 
 Development of a defensive system is critical to ensure the survival of prey species. The 
outbred Long-Evans rat, which belongs to Rattus norvegicus, has developed that ability to emit 
22-kHz USVs as a defensive alarm call. The idea that 22-kHz USVs represent an alarm call or a 
defensive vocalization was first championed by a seminal publication by Blanchard and 
Blanchard (1991). The paper described the behaviour of rats after a predator was introduced into 
their immediate environment, which induced the emission of 22-kHz and subsequent immobility 
in the rats living within a visible burrow system. These USVs were seen long after the cat was 
removed and were argued to act as a method of transmitting the proximity of a predator to the 
colony. Evidence that further supports the conclusion that 22-kHz USVs are produced in 
aversive circumstances are demonstrated in experiments that utilize playback recordings, social 
transmission of fear and c-fos-immunoreactivity in response to 22-kHz USVs (Wöhr and 
Schwarting 2011).  
A method for testing the ability of 22-kHz USVs to alter the behaviour of a receiver is to 
play the ultrasounds through a specialized speaker system and quantify the locomotor activity 
and behaviour of the receiver. If the animal executes motor patterns consistent with fear or 
anxiety it will become immobile or execute hopping and jumping motor patterns that are akin to 
escape behaviours (Brandão et al., 2008). Brudzynski and Chiu (1995) induced and recorded 22-
kHz USVs and subsequently played the aversive 22-kHz back to rats for several seconds. During 
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the playback of the 22-kHz USVs recording, the locomotion of the rats did not change, but once 
the ultrasound was terminated the rats showed significant decreases in locomotion (Brudzynski 
and Chiu, 1995). Although these studies used recording of a tactile-induced 22-kHz USVs 
similar results are reported in studies using pair-housed rats to socially transmitted 22-kHz 
USVs.  
Kim and colleagues (2010) reported results that demonstrated the defensive behavioural 
changes that occur in the receiver of 22-kHz USVs during fear conditioning and pair-testing. 
Using a fear conditioning chamber, Kim and colleagues (2010) conditioned one animal to a 
pairing of a tone and foot shock. After the animal had acquired conditioned fear, which was 
assessed by freezing and the production of 22-kHz USVs in the chamber, the conditioned animal 
was placed with a naїve cage mate in a novel chamber. During the initial phases of the pairing, 
both animals showed normal exploratory behaviour but once the conditioned tone was presented 
both animals showed freezing behaviour and production of 22-kHz USVs for the entire 8 minute 
testing session (Kim et al, 2010). These results support the original argument presented by 
Blanchard and Blanchard (1991) that 22-kHz USVs induce defensive behaviours in the receivers.   
Further support to the idea that aversive semiotic content is carried by 22-kHz USVs to 
the receivers is highlighted by c-fos immunoreactivity experiments. Using playback of naturally 
induced 22-kHz USVs Sadananda and colleagues (2007) reported differential Fos-like 
immunoreactivity in key brain regions that are associated with fear and anxiety. Fos-like 
immunoreactivity was significantly increased in regions of the midbrain and forebrain of the rat, 
and included structures such as the lateral amygdala and the periaquductal gray (PAG; 
Sandananda et al, 2007). Electrophysiological analysis has reported that all the above-mentioned 
nuclei are involved in fear conditioning and defensive behavioural responses. 
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 Using an auditory conditioning paradigm that was paired with foot-shocks, Quirk and 
colleagues reported that almost a quarter of the neurons within the lateral amygdala showed 
increases in firing rates compared to controls in response to a conditioned tone (Quirk et al., 
1995). In agreement with the idea that the lateral amygdala is involved in acoustic emotional 
states, lesions placed within the lateral amygdala disrupt emotional conditioning (LeDoux et al., 
1990). It is also interesting to note that the lateral amygdala receives dense projections from the 
acoustic thalamus (LeDoux et al., 1990). This would position the lateral amygdala to process 22-
kHz USVs and send the information to relevant brain structures such as the PAG to execute a 
variety of behavioural responses such as freezing, changes in autonomic activity, execution of 
defensive behaviour or analgesia (Bessen et al., 1992; Bandler and Shipley, 2003).  
The production of 22-kHz USVs is not limited to the approach of a predator or in 
anticipation of aversive stimuli but can be produced under a number of different socially aversive 
situations. The productions of 22-kHz USVs have been observed during social defeat after the 
introduction of an intruder male into a “resident” male’s cage (Burgdorf et al, 2008). Aggression 
was indexed by the number of bites (>3) the “intruder” received and vocal analysis showed a 
large increase in the defeated animal to produce 22-kHz USVs (Burgdorf et al, 2008).  Aversive 
22-kHz USVs have also been recorded by investigators during aversive handling (Brudzynski 
and Ociepa, 1992), application of a jet of air to the head of the rat (Knapp and Pohorecky, 1995), 
when the rat is acoustically startled (Kaltwasser, 1990), when the rat anticipates the application 
of a foot-shock (De Vry et al, 1993), or during auditory or visual fear conditioning (Jelen et al., 
2003).  
Pharmacological evidence also supports the notion that 22-kHz USVs index a negative 
emotional state of the rat. Anxiolytics are drugs that decrease the self-indexed report anxiety in 
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the human population while anxiogenics are drugs that can increase the self-indexed report of 
anxiety within the human population. Drugs that are typically classified as anixolytics or anti-
depressants including diazepam, chlordiazepoxide, meprobamate, pentobarbital, and gepirone, 
significantly decrease the number of emitted 22-kHz USVs in conditioned fear paradigms (De 
Vry et al, 1993). In contrast anxiogenics such as PTZ and FG-7142 have the ability to increase 
the production of 22-kHz USVs in conditioned fear paradigms over controls (Jelen et al, 2003). 
Neural systems associated with the initiation of defensive behaviours and the 22-kHz USVs 
  Behaviours are external manifestations of internal processes occurring throughout the 
nervous system. If 22-kHz USVs are components of a large “defensive” mechanism of the rat 
then there should be discrete nuclei localized within the rat brain that are predisposed to the 
production of defensive behaviors, and subsequently the production of 22-kHz USVs. 
 Investigations of the brain nuclei that are responsible for assembling defensive 
behaviours in the animal began with decorticated dogs and cats. These decorticated animals 
would show extreme emotional reactivity to benign sensory stimuli like pinching the tail of the 
animal, a fly landing on the nose, or being removed from their home cage (Bard, 1929; 1934). To 
explain these emotional disturbances in the decorticated animal subjects, Cannon put forth a 
proposed diencephalic mechanism of emotion, focusing on the thalamus (Cannon & Newton, 
1929). The conceptual frame work of Cannon’s model was the processes of disinhibition of the 
thalamus by specific patterns of cortical activity (Cannon, 1927).  The pattern of disinhibition 
from the thalamus would produce different emotional or affective states. This information would 
then be transmitted to the motor system to initiate the expression of the current emotion (Cannon, 
1927). The investigation of defensive circuits localized within the brain was furthered by Bard.  
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Bard was able to show that the neural regions responsible for organizing defensive 
behaviours in cats were not localized within the thalamus but rather were localized within the 
hypothalamus. Bard decorticated cats while at the same time systematically destroyed specific 
parts of the forebrain or midbrain in the cat. Decorticated cats that also had their thalamus 
damaged were still able to produce stereotypical rage responses which included protrusion of 
claws, lashing of the tails, rapid panting, snarling, spitting, piloerection, and sweating from the 
pads of the feet. Animal subjects that were decorticated and also had damage to the 
hypothalamus or damage extending into the brain stem failed to produce any behavioural 
reactions to benign stimulation (Bard, 1929). Bard ended up correctly concluding that the 
hypothalamus was responsible for organizing defensive behaviours in cats as long as the 
hypothalamus remained intact with the brainstem.  
The hypothesis that Bard derived about the hypothalamus being able to coordinate 
defensive behaviours was later supported by Hess. Hess used electrical stimulation of brain 
structures located in the forebrain and midbrain of the cat that were involved in the organization 
and expression of defensive behaviours. Hess’s investigation in cats showed circumscribed 
regions in the hypothalamus that were responsible for affective defense reactions and included 
the medial preoptic area and perifornical area (Hess and Akert, 1955). The defensive reaction in 
cats that Hess was able to induce by electrically stimulating the hypothalamus was akin to the 
defensive reactions described by Bard and Cannon in their decorticated cats. Although the 
hypothalamus was correctly identified as being necessary for the production of defensive 
behaviours, electrical stimulation made it impossible to identify the different neurochemicals or 
specific neural pathways that are responsible for initiating such complex defensive behaviour. 
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The technique of electrical stimulation was very good at exciting nerve cells but the 
technique was non-specific and could excite fibers of passage leading to the activation of 
undesired nuclei. This led to problems of correlating behaviours that were organized by brain 
nuclei. The problem of electrical stimulation was later replaced by the technique of intracerebral 
injections. This technique allows for chemicals to be directly injected into nuclei of the subject’s 
brain. Since fibers of passage do not respond to transmitters, they are not influenced by the 
injected chemicals. The method of intracerebral injections was used to shed light on the 
neurochemicals that were involved in the initiation of defensive response in cats.  
The method of intracerebral injections was able to provide evidence that implicated 
acetylcholine in the initiation of defensive reactions in the cat when injected into the medial and 
anterior parts of the hypothalamus (Brudzynski, 1981a, b).  Injection of carbachol, a cholinergic 
agonist specific for muscarinic receptors, into the anterior and medial parts of the hypothalamus 
(AH-MPO) were able to produce somatic and behavioral components of defensive responses that 
were consistent with defensive behaviors reported by Hess (1955), Cannon (1927) and Bard 
(1928).  This provided evidence that the initiation of defensive behaviour in the cat was 
somehow dependent upon acetylcholine being released from the terminal bouton, diffusing 
across the synaptic cleft, and binding to muscarinic acetylcholine receptors along the midbrain-
forebrain continuum.  
In the cat cholinergic innervation of the anterior and medial parts of the hypothalamus 
originates from the laterodorsal tegmental nucleus (LTDg), a group of cholinergic cell bodies 
located within the mesopontine tegmentum (Kimura et al, 1981). These cholinergic cell bodies 
project and innervate parts of the hypothalamus and other subcortical structures such as the 
lateral septum (LS). This cholinergic anatomical projection system that innervates parts of the 
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hypothalamus responsible for organization and initiation of defensive behaviours in cats is also 
found in Long-Evan rats (Paxinos and Watson, 1986; Chiba & Murata, 1985; Cornwall et al, 
1990). 
In rats, the LTDg has a similar trajectory to cats and also has the ability to initiate 
defensive displays (Brudzynski,and Barnabi, 1996). Stimulation of the LTDg in the rat by direct 
injection of the excitatory amino acid glutamate can cause robust initiation of species-typical 22-
kHz USVs alarm calls (Brudzynski and Barnabi, 1996).  These defensive 22-kHz USVs can be 
significantly reduced if the anterior hypothalamic – medial preoptic region (AH-MPO) of the rat 
is pretreated with the muscarinic antagonist scopolamine (Brudzynski and Barnabi, 1996). The 
parameters of the 22-kHz USVs that are produced under pharmacological initiation do not 
significantly differ from defensive alarm calls that are produced by a rat in response to a predator 
(Brudzynski, 2007).  
The production of defensive 22-kHz USVs in rats can also be initiated by carbachol being 
injected into extra-hypothalamic brain regions localized within the basal forebrain. Injection of 
carbachol into the lateral septum (LS) can initiate 22-kHz USVs (Bihari et al, 2003). Similarly, 
22-kHz USVs induced by glutamate injections into the LTDg can be decreased by pretreatment 
of the LS with atropine or scopolamine, both of which are muscarinic antagonists (Bihari, et al, 
2003).  Both the LS and the AH-MPO are nuclei that belong to a larger system of brain 
structures arranged along the midbrain-forebrain continuum termed the medial ascending 
cholinoceptive vocalization strip (Brudzynski, 2007). Brain structures that are localized within 
the medially ascending strip are able to produce 22-kHz USVs in response to injection of 
carbachol or are able to decrease glutamate induced 22-kHz USVs from the LTDg by prior 
application of muscarinic antagonists.  
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The ascending cholinoceptive vocalization strip was defined as a longitudinally arranged 
strip of tissue that extends from the mesencephalon to the basal forebrain that is involved in the 
production of defensive alarm vocalization (Brudzynski 2007; 2010; 2011). Although this system 
was first investigated in the cat (Brudzynski, 1981a, b) it has become extensively investigated 
within the rat. The system functions in an ascending manner whereby excitation of the LTDg 
causes the subsequent release of acetylcholine in the AH-MPO, LS and other target sites to 
initiate defensive behaviours, such as the production of 22-kHz USVs.  
Conclusions from the production of 22-kHz USVs in rats 
From the described behavioural and pharmacological evidence it is apparent that the 
production of 22-kHz USVs represents a defensive vocal behaviour in the rat. This behaviour 
can be initiated in behavioural experiments involving conditioned fear, or negative social 
interactions. Aversive 22-kHz USVs can also be induced pharmacologically by carbachol given 
into synapses along the ascending cholinoceptive vocalization strip. In rats, as in cats, one of the 
key neurotransmitter receptor that is involved in initiating defensive behaviours is the muscarinic 
acetylcholine receptor. 
50-kHz ultrasonic vocalizations are correlated with positive valenced behaviours  
 Similarly, as with 22-kHz USVs, in order to establish that the production of 50-kHz 
USVs indexes positive emotional states in rats some behavioural and chemical criteria should be 
satisfied. Since humans report that positive pro-social contact is involved in the self-report of 
positive valence (Csikszentmihalyi & Hunter, 2003), the production of 50-kHz USVs should be 
induced by positive pro-social encounters amongst conspecifics (Knuston et al, 2002). From a 
pharmacological perspective, appetitive 50-kHz USVs should be induced by manipulations of 
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brain structures and neurotransmitters that have been reported to be associated with positive 
emotional valence in humans.  
Behavioural changes associated with the production of 50-kHz USVs 
 There are primarily two pro-social circumstances in which the production of 50-kHz 
USVs can be initiated. These circumstances can be broken down into vocalizations that are 
involved in communication during sexual encounters between male and female participants and 
communication between conspecifics during non-sexual social encounters. During sexual 
encounters the 50-kHz USVs are produced by both male and female partners (Thomas & 
Barfield, 1985; McIntosh & Barfield, 1980; White et al, 1993) and promote sexual contact 
between the pair. Production of 50-kHz USVs by the male is able to increase the incidence of 
darting and ear-wiggling in the female (Thomas, 1981), both of which are signs of proceptivity 
in the female (Thomas et al, 1982).  Moreover, when estrous females are placed with devocalized 
males (males whom had laryngeal nerve resection) their proceptive behaviour is impaired but 
can be restored by the playback of male 50-kHz USVs (Geyer & Barfield, 1978).  In sexual 
situations 50-kHz USVs play a pivotal role promote receptive behaviours in the female and male 
rat (Wöhr & Schwarting, 2010).  
 Appetitive 50-kHz USVs are also produced during non-sexual pro-social contacts in rats. 
Strong evidence that supports such a social role for 50-kHz USVs is demonstrated by rough-and-
tumble play experiments (Knutson et al., 1998). During rough-and-tumble play between 
adolescent rats, one rat will dart on the back of a partner with their forepaws (also known as 
dorsal contact) and direct a play bite to the nape of the partner’s neck. The partner in defense will 
orient its posture into a supine position to defend against its neck from the play attacks. This 
allows the attacker to playfully “pin” the defender (Panksepp, et al, 1984; Siviy & Panksepp, 
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1987; Smith et al, 1998; Knuston et al, 2002).  Rough-and-tumble play behaviour is presumed to 
be rewarding because animals show place preference for spaces where they have experienced 
play and will emit 50-kHz USVs in anticipation of play (Knuston et al, 2001). Another 
behavioural measure used to quantify that play is a form of appetitive behaviour is latency of 
approach. 
 Latency of approach is the duration it takes for a partner to make contact with their 
conspecific to induce play behaviour. The longer the time the animal takes to make dorsal 
contact represents less drive for the animal to engage in play behaviour. If the animal 
demonstrates a short latency it means the more drive the animal has to engage in play behaviour. 
Using “tickling” procedure, an experimenter mimics the behaviour of two adolescent rats during 
rough-and-tumble play by making dorsal contact with a adolescent rat and flipping of the animal 
into a supine position. Quantifying latency of approach of the animal during ticking and number 
of 50-kHz USVs Burgdorf & Panksepp (2001) found a negative correlation between numbers of 
50-kHz USVs emitted and approach latency for tickling (Burgdorf & Panksepp, 2001). This 
means the high number of produced 50-kHz USVs, the more eager animals are to engage in 
contact with the experimenter.  
 Rats not only produce 50-kHz USVs during play but, when given the opportunity, they 
will eagerly search out the source of emitted 50-kHz USVs. Using an operant sound-sample self-
administration chamber, Burgdorf and colleagues (2008) were able to show rats will nose-poke 
for continuous playback of 50-kHz USVs over tape hiss and 22-kHz USVs (Burgdorf et al., 
2008). Similar results were also reported by Wöhr and Schwarting (2007). Playback of 50-kHz 
USVs was able to activate behavioural changes from the animal within a radial arm maze to 
approach the source of emitted 50-kHz USVs.  This ability of 50-kHz USVs to induce approach 
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was not dependent on juvenile or adult male rats; however some behavioural differences did 
exist between the two groups. Juvenile rats approached the source of 50-kHz USVs with a 
smaller latency then did adult rats however, adult rats emitted 50-kHz USVs in response to 
playback of 50-kHz USVs. Although these behaviours were different, both behaviours still 
displayed the characteristics of appetitive pro-social behaviour.  
 In rat brain, the processing of 50-kHz USVs is associated with multiple brain structures 
that are not active during processing of 22-kHz USVs. Rats show increased Fos-immunoreactive 
protein in sites that are consistent with reward and self-stimulation such as the lateral 
hypothalamus and the ventral striatum (Sadananda et al, 2008). These results suggest that the 
signal the 50-kHz USV carries is appetitive when decoded by the receiver.    
Regions of the brain associated with reward and appetitive emotional states 
 Electrical stimulation of the brain is a powerful experimental method to probe the 
contribution of various brain regions to organized behaviour. Its application and subsequent use 
for mapping neural structures associated with reward, and subsequently pleasure, was first 
demonstrated by Olds and Milner (1954) who were interested in brain regions associated with 
reinforcing functions. Olds and Milner demonstrated that rats would develop place-preferences 
behaviours when experiencing an electrical current to different brain areas. Also, animals in 
operant conditioning experiments would quickly learn to perform a task, such as lever pressing, 
to receive electrical stimulation of brain areas (Olds and Milner, 1954). This led Olds and Milner 
to the notion that there are distinct regions in the brain that are dedicated to reward, which are 
used to change and reinforce the behaviour of animals.  
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 A partial clue to the neurochemical mediators that contribute to reward stemmed from 
clinical observations that schizophrenics had decreased self-reports of pleasure from rewarding 
stimuli (i.e. food and sex) while on anti-psychotic drugs. Animal studies employing self-
administration reserpine, imipramine and chlorpromazine (Stein, 1962) attenuated rewarding 
self-administration behaviour in rats. This led to the hypothesis that noradrenaline was involved 
in the reward system. In support of this hypothesis Wise and Stein (1969) injected sodium 
diethyldithiocarbamate and disulfiram, drugs that inhibit dopamine-β-hydroxylase (Szmigielski, 
1975), and reported that rats decreased medial forebrain bundle electrical stimulation (Wise and 
Stein, 1969), a behaviour associated with reinforcement and reward (Hernandez et al, 2006). 
This evidence was argued by Stein and colleagues as support that noradrenalin mediates reward. 
Anatomical and pharmacological evidence would soon refute this hypothesis and replace it with 
another catecholamine.  
 Experiments combining self-injection protocols and anatomical-mapping experiments 
began to contradict the noradrenalin hypothesis of reward. Yokel and Wise (1975) showed that 
injection of noradrenergic antagonists did not disrupt the intravenous administration of 
amphetamine (Yokel & Wise, 1975) or cocaine (De Wit & Wise, 1977).  Also destroying the 
ascending dorsal noradrenergic fiber bundle was unable to disrupt intracranial self-administration 
in rats. Later experiments that utilized dopaminergic antagonists were able to show clear 
decreases in self-administration experiments and thus a decrease in reward acquisition (Rolls, 
1974; Rolls et at, 1975). Slowly the noradrenalin hypothesis of hedonia was replaced with the 
dopamine hypothesis of motivation and hedonia (Wise et al., 1978). 
 The anhedonia hypothesis was a major contributor to the hypothesis regarding the 
function of dopamine in reward and pleasure (Wise, 2008).  Dopamine containing cells are 
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scattered along the base of the mesencephalon and are grouped into mesocortical, mesolimbic 
and nigrostriatal systems (Ikemoto & Panksepp, 1999; Ikemoto, 2007). The mesocortical 
dopamine system contains cell bodies that are localized within the ventral tegmental area (VTA) 
that ascend and innervate aspects of the medial prefrontal cortex in rat. The nigrostriatal system 
contains dopamine cell bodies that are localized in the substantia nigra and ascend to innervate 
aspects of the striatum, a major input structure for the basal ganglia (Feldman et al, 1997). This 
pathway plays an important regulation in locomotor behaviour since damage to this system can 
cause Parkinsonism-like behaviours (Ungerstedt & Arbuthnott, 1970). Finally the mesolimbic 
system contains dopamine cell fibers that originate within the ventral tegmental area and ascend 
through the medial forebrain bundle to terminate in forebrain regions responsible for motivation 
and emotional regulation in the animal (Feldman et al, 1997). These brain sites include the 
ventral striatum, more specifically nucleus accumbens, amygdala, and hippocampus. The 
mesolimbic dopamine system has been intensively investigated because its pathophysiology is 
implicated in addiction. 
The striatum and its ventral division 
 The striatum can be divided into a ventral and dorsal tier. The dorsal striatum comprises 
the caudate-putamen and receives the majority of afferents from glutamatergic pyramidal cells of 
the cortical mantle (Delong & Wichmann, 2007). The excitatory input from the cortical mantle 
converges onto interneurons and medium spiny-projection neurons that in turn influence the 
activity of motor related nuclei such as the dorsal pallidum, and subthalamic nucleus (Afifl, 
1994). The dorsal striatum has thus been categorized as belonging to the basal ganglia, a set of 
nuclei involved motor sequencing (Gerfen and Wilson, 1996). 
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 The ventral extension of the caudate-putamen is known as the ventral striatum and 
includes the nucleus accumbens and olfactory tubercle (Zahm & Brog, 1992). Although the 
olfactory tubercle is involved in the classification of the ventral striatum, this nucleus will not be 
included when talking about the divisions of the nucleus accumbens in this thesis, and 
subsequent usage of the ventral striatum will only refer to the nucleus accumbens. The nucleus 
accumbens is a sheet of gray matter located in the rat forebrain. In its caudal aspect it merges 
without clear distinction with the extended amygdala,  is bounded by the external capsule in 
rostral and lateral directions (Ikemoto, 2007) and medially by the lateral ventricles and the 
septum (Humphries and Prescott, 2010). Based on anatomical and histochemical markers the 
nucleus accumbens can be divided into core and shell regions. 
 Histochemical markers can distinguish between core and shell regions of the nucleus 
accumbens (Zaborszky et al, 1985). The core of the nucleus accumbens stains densely for the 
calbindin, while the shell of the accumbens stains heavily for the calcium binding protein 
calretinin, and acetylcholine esterase (Bubser et al, 2000). These differences in histochemical 
organization were correctly argued to represent different functional units. Analyzing the afferent-
efferent relationship of the core of the nucleus accumbens revealed connections with brain nuclei 
involved motor processing such as the subthalamic nucleus, while the shell of the nucleus 
accumbens revealed connections with limbic structures involved in motivation and emotional 
regulation, such as the VTA (French and Totterdell, 2003; Goto & Grace, 2005; Heimer et al., 
1991).  
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Relationship between the VTA and the shell of the nucleus accumbens during self-administration 
tests 
Electrical stimulation of the MFB or the lateral hypothalamus in rats has shown to 
produce behaviours indicative of positive valence and reward (Olds and Milner, 1954). Support 
that dopamine release in the nucleus accumbens is involved in rewarding aspects of electrical 
stimulation comes from experiments employing chronoamperometry and high performance 
liquid chromatography. Chronoamperometry is able to measure dopamine oxidation currents 
while high performance liquid chromatography is able to measure the dopamine metabolites 3, 4- 
dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA). Both forms of 
neurochemical detection showed increases in dopamine release in the shell of the nucleus 
accumbens in response to rewarding self-administration of electrical current to the MFB and 
VTA (Fibiger et al, 1987; Blaha & Philips, 1990; Philips et al., 1992). Interestingly, drugs that 
are abused by humans for their hedonic value (opiates, ethanol, nicotine, amphetamine, and 
cocaine; Bock et al, 2007), are all able to increase the endogenous levels of dopamine within the 
nucleus accumbens of the rat when injected systemically (Di Chiara & Imperato, 1988) and a 
subset of these compounds that are abused by humans can produce 50-kHz USVs in rats 
(Thompson et al, 2006).  
 Damage to the nucleus accumbens can disrupt self-administration of drugs in rats. 
Injection of 6-hydroxydopamine, a specific dopamine neurotoxin, bilaterally into the nucleus 
accumbens disrupts the acquisition and maintenance of self-administration of d-amphetamine 
without deficits in locomotor behaviour (Lyness et al, 1979). Destruction of dopamine fibers also 
diminishes the rates of cocaine self-administration (Roberts & Koob, 1980) and decreases the 
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rate of MFB self-stimulation (Steller & Corbett, 1989) suggesting the integrity of the mesolimbic 
dopamine system is needed for reward aquisition. 
The chemical constituents responsible for the production of 50-kHz USVs in rats 
 If the dopamine hypothesis of pleasure and positive affect is correct, then ingestion of 
drugs of abuse that are commonly associated with euphoria in human subjects should increase 
dopamine transmission within the mesolimbic dopamine system of the rat. Drevets and 
colleagues (2001) combined positron emission tomography to correlate changes in dopamine 
levels following amphetamine administration with hedonic self-reports. The authors reported that 
amphetamine increases endogenous dopamine levels within the ventral striatum of human 
subjects in response to amphetamine ingestion, and this increase in dopamine release is 
positively correlated to hedonic responses in the subjects (Drevets et al., 2001). Since 
amphetamine increases the self-indexed report of hedonia in human subjects, then injection of 
amphetamine into the ventral striatum of the rat should produce robust, species-typical 50-kHz 
USVs since this vocalization indexes appetitive states in the rat. Results reported by Thompson 
and colleagues (2006) and Burgdorf and colleagues (2001) support such a prediction. Thompson 
and colleagues (2006) reported the production of 50-kHz USVs in response to amphetamine 
injections into the shell of the nucleus accumbens during a quantitative mapping study. This 
increase in 50-kHz USVs was mediated by dopamine since pretreatment of the nucleus 
accumbens with SKF-83566 or raclopride, both dopamine antagonists, reduced the number of 
recorded 50-kHz USVs (Thompson et al, 2006). The results of Thompson and colleagues are 
consistent with Burgdorf and colleagues, who also reported that amphetamine increases the 
production of 50-kHz USVs when injected into the medial shell of the nucleus accumbens 
(Burgdorf, 2001).  
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 Further support that dopamine regulates the initiation of appetitive 50-kHz USVs comes 
from recording of 50-kHz USVs during anticipation of rewarding situations. Burgdorf and 
colleagues (2000) showed that rats, when anticipating an electrical stimulation of the VTA or the 
lateral hypothalamus (LH), showed significant increases in the production of 50-kHz USVs 
(Burgdorf et al., 2000). Injection of raclopride, a dopamine receptor antagonist, decreases the 
number of 50-kHz USVs (Thompson et al, 2006) in response to both rough-and-tumble play and 
in anticipation of rewarding brain stimulation (Burgdorf et al., 2007). Systemic injections of 
flupenthixol, another type of dopamine receptor antagonist, produces deficits in the production of 
50-kHz USVs in response to “tickling” and anticipation of electrical stimulation in a similar 
manner to animals that have had electrolytic lesions placed in the VTA (Burgdorf et al, 2007).  
Closing remarks on dopamine and the production of 50-kHz USVs 
 The production of 50-kHz USVs indexes an appetitive state within the signaler. These 
vocalizations are produced under positive pro-social circumstances and can be 
pharmacologically induced by the systemic injections of drugs of abuse, or when injected into 
the ventral striatum. The messages that these vocalizations carry seem to be involved in the 
maintenance or re-establishment of social contact amongst conspecifics since they are used 
during mating and adolescent play and in response to playback recordings of 50-kHz USVs. 
These vocalizations are also accompanied by approach like locomotor changes in the receiver of 
the animal towards the source of emitted 50-kHz. These behaviours are opposite reactions to 
animals responding to 22-kHz USVs. Thus, 50-kHz USVs are produced under appetitive 
circumstances and can index the appetitive emotional state in the signaler.  
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The ascending mesolimbic dopamine system and the ascending mesolimbic cholinergic system 
 The production of 50-kHz USVs and the production of 22-kHz USVs are dependent upon 
two separate neurochemical systems. The production of appetitive 50-kHz USVs is dependent 
upon the release of dopamine into the medial shell of the nucleus accumbens, while the 
production of 22-kHz USVs is dependent upon acetylcholine being released into the terminal 
fields of the medial cholinoceptive vocalization strip. These two ascending systems in the rat 
represent two functionally separate emotional systems. Functionally, this means that during the 
production of 50-kHz USVs the probability of producing 22-kHz USVs is diminished and vice 
versa. 
 Electrophysiological evidence also indirectly suggests these two systems function in 
opposition to each other. Since the ascending mesolimbic dopamine system is involved in 
behavioural responses associated with appetitive emotions, these dopamine containing cell 
bodies within the VTA should be inhibited during aversive situation. Indeed, there have been 
many electrophysiological reports showing such a relationship. Mileykovskiy and Morales 
(2011) recorded the electrophysiological behaviour of tyrosine hydroxylase positive neurons 
(TH+; a marker for dopamine neurons) in the parabrachial pigmented and paranigral nuclei (part 
of the ventral tegmental area) to aversive fear conditioning. The authors reported significant 
decreases in the discharge rates of dopamine neurons during anticipation of an electrical tail 
shock and decreased respiratory activity of the animals (Mileykovskiy and Morales, 2011). 
These results are similar with Mirenowicz and Schultz study reporting a preferential activation of 
dopamine containing VTA neurons to rewarding stimulation and a preferential inhibition of 
dopamine containing VTA neurons to negative stimulation (Mirenowicz and Schultz, 1996). 
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These results suggest an inverse relationship between reward and punishment responses encoded 
by the properties of dopamine neurons within the VTA. 
 Despite the work involving the different circumstances in which the production of 22-
kHz or 50-kHz USVs can be emitted, no investigation has sought out to establish a relationship 
between the two neural systems that are responsible for the production of either 22-kHz USVs or 
50-kHz USVs. So far the work has only been indirect. This thesis focused on investigating the 
relationship between the two neural systems responsible for both emotional expression states in 
rats.   
Central Question 
 If the mesolimbic dopamine system and the mesolimbic cholinergic system represent two 
different pathways regulating different emotional states in rats, then do these systems interact? 
And if so, what is the nature of this interaction? Another question that was investigated 
throughout this thesis was if the parameters of 22-kHz or 50-kHz USVs changed upon activation 
of the antagonistic systems. 
Hypothesis 
 The production of 22-kHz USVs indexes emotionally aversive states in the signaler. The 
production of aversive 22-kHz is dependent upon the release of acetylcholine into the terminal 
fields along the medial cholinoceptive vocalization strip. The production of 50-kHz USVs 
indexes an emotionally appetitive state in the signaler and can be initiated by injection of 
dopamine agonists into the medial shell of the nucleus accumbens. Since these two systems are 
functionally antagonistic to each other, activation of the ascending mesolimbic dopamine system, 
before injection of carbachol into the medial cholinoceptive vocalization strip, will attenuate the 
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number of 22-kHz USVs reflecting a functional antagonism of the aversive emotional state. 
Conversely, activation of the ascending mesolimbic cholinergic system involved in negative 
emotional states will attenuate the number of 50-kHz USVs induced by injection of a dopamine 
agonist into the medial shell of the nucleus accumbens, reflecting a functional antagonism of an 
appetitive emotional state.  
Although the two systems governing the emotional expression of 22-kHz USVs and 50-
kHz USVs are antagonistic to each other, the characterization of emitted USVs will not change 
in any condition because the duration and peak frequency of the USVs is critical for properly 
transmitting biologically important information.  
Goals and Predictions  
 The goal of this thesis was to provide evidence of the mutually antagonist relationship 
between the aversive-emotional system responsible for the production of 22-kHz USVs and the 
appetitive-emotional system responsible for the production of 50-kHz USVs. Activation of the 
ascending mesolimbic dopamine system was done by injection of apomorphine into the medial 
shell of the nucleus accumbens while activation of the ascending mesolimbic cholinergic system 
was done by injection of carbachol into the AH-MPO and the LS. The following predictions 
were proposed based on the functional antagonistic relationship of the ascending mesolimbic 
dopamine system and ascending mesolimbic cholinergic system: 
1) Apomorphine, when injected into the shell of the nucleus accumbens, will dose-
dependently induce the emission of 50-kHz USVs 
2) Carbachol-induced 22-kHz USVs from the AH-MPO or LS will be blocked or decreased 
by earlier injection of apomorphine into the medial shell of the nucleus accumbens 
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3) Apomorphine induced 50-kHz USVs from the medial shell of the nucleus accumbens will 
be blocked or decreased by earlier injection of carbachol into the AH-MPO or the LS 
4) Antagonism of the emotional systems will not change the parameters that define the 
characteristics of aversive 22-kHz USVs or appetitive 50-kHz USVs. 
Rationale for apomorphine use 
 Amphetamine is a potent pharmacological compound that can increase the endogenous 
level of dopamine with the nucleus accumbens and can unconditionally initiate the production of 
50-kHz USVs (Burgdorf et al, 2001). However, the range of pharmacological compounds 
classified as dopamine agonists which can initiate 50-kHz USVs have been limited to 
amphetamine or cocaine (which was given systemically). In this thesis another dopamine 
agonist, apomorphine, will be used to see if it can also initiate 50-kHz USVs in rats. This will 
provide further support to the hypothesis that dopamine release in the nucleus accumbens is 
sufficient for the initiation of 50-kHz USVs.  
 Enantiomers of apomorphine, R-(-)-apomorphine and S-(-)-apomorphine, are widely 
studied class of pharmacological alkaloids with broad spectrum affinity for both D1 and D2 class 
of dopamine receptors (Kula et al, 1985; Saller & Salama, 1986). In binding assays, it has been 
demonstrated that the R-(-) configuration of apomorphine can stimulate dopamine receptor-
mediated adenyl-cyclase (Kula et al., 1985), activate dopamine autoreceptors located on the 
soma of dopamine neurons (Saller & Salama, 1986) and can compete with spiroperidol, a known 
dopamine antagonist (Kula et al., 1985). Actions of the R-(-) configuration can be antagonized 
by co-application of dopamine receptor antagonists like haloperidol and sulpride, suggesting that 
R-(-) configuration functions by binding to dopamine receptors and initiating biological cascades 
that are akin to dopamine binding to dopamine receptors. Behavioural experiments testing the 
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locomotor activity of animals injected with apomorphine show similar behvioural patterns to 
animals injected with amphetamine. Animals, when injected with the R-(-) configuration show 
increased cage climbing (Wilcox et al, 1979), increased locomotor activity (Kiyatkin, 1994) and 
increased gnawing compulsion in rodents (Ernst, 1967). These behavioural and biochemical 
responses were not observed with the S-(-)-apomorphine (Campell et al., 1984). Since the 
behaviours produced by R-(-)-apomorphine are similar to those produced by amphetamine, and 
since amphetamine can initiate the production of 50-kHz USVs when injected systemically or 
into the shell of the nucleus accumbens, this thesis will focus on R-(-)-apomorphine and its 
ability to produce 50-kHz USVs.  
 To initiate the production of aversive 22-kHz USVs in rats for this thesis, 1.0 µg of 
carbachol (a muscarinic cholinergic agonist) will be injected into the terminal fields of the 
medial cholinoceptive vocalization strip localized to the AH-MPO and the LS. Dose-response 
curves indicate that 1.0 µg is able to induce the maximal response of emitted 22-kHz USVs 
(Bihari et al, 2003).  
Methods and Materials 
Experimental Subjects 
The animals used throughout this thesis were 60 adult, male Long Evans rats weighing 
between 250-370 grams. Upon arrival to the Brock University animal facility from Charles 
River, Montreal Quebec, the animals were housed in 560 mm x 250 mm x 195 mm 
polycarbonate cages for three days to acclimate to the new facility. The animals were housed 
with one large black polyvinyl tube and 4 sheets of paper towel to provide hiding place and to 
enrich their environment. All experimental procedures carried out on the animal subjects were 
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done in accordance with the Canadian Council on Animal Care (CCAC) and were approved by 
the Brock Animal Care Committee. All surgical procedures and post-operative care were done 
with the supervision of an appointed veterinarian. Experimentations began five days after 
surgical procedure on healthy post-operative rats. All rats were healthy throughout the study and 
showed species-typical behaviour. 
Stereotaxic Surgeries 
For intracerebral injections, rats needed to have cannulae surgically implanted into their 
brain. Rats were prepared for surgery by receiving an intraperitoneal mixture of ketamine (40 
mg/kg, MTC Pharmaceuticals, Cambridge, Ontario) and xylazine hydrochloride (6 mg/kg, 
Chemargo Ltd., Ontario). After proper sedation and depth of anesthesia, the animals received an 
injection of trimethoprim and sulfadiazine (1:5) at a dose of 240 mg/kg to prevent bacterial 
infections and metacam (2 mg/kg) to provide pain management. Under full anesthesia, the 
animal’s heads were shaved and then placed into a Kopf stereotaxic apparatus (David Kopf 
Instruments, Tujunga, CA). Once properly mounted, the surgical site was scrubbed with 7% 
iodine solution combined with detergent. The detergent was cleared off the scalp by 70% 
isopropanol and then the area was locally re-sterilized with 10% iodine. After proper skin 
treatment, an incision was made with a # 20 scalpel blade in the rostro-caudal direction. After the 
incision was made, the periosteum was scraped away revealing the underlying skull and its 
anatomical features.  The arm of the stereotaxic device was then calibrated according to the 
position of lambda stereotaxic zero on the surface of the skull. After small holes were drilled into 
the skull, 23 gauge stainless-steel guide cannula were unilaterally implanted into the left nucleus 
accumbens shell (A=9.7 – 10.33 mm, L= 0.8-1.3 mm, V= - 6.4 to -6.6 mm), left anterior 
hypothalamic-medial preoptic area (A = 7.8 to 8.4 mm, L=0.2 to 0.8 mm, V= -8.5 to -8.8 mm) or 
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left lateral septum (A=9.6 to 9.8 mm, L=0.4 to 0.6 mm, V= -4.5 to -5.2 mm). All coordinates 
were taken from lambda (Paxinos & Watson, 1986). 
Following cannulae implantation, methyl methylacrylate resin (Hygenic Corporation of 
Canada, St. Catharines, Ontario) was used to permanently secure the implant to the skull. The 
opening of the cannula was blocked by inserting a stainless steel wire plug into the guide 
cannula. After surgery, the animal was given the analgesic meloxicam at a dose of 2-5 mg/kg s.c. 
Animals were then placed in post-surgery cages suspended on a grate. After the animal had 
recovered, they were placed back into their pre-surgical environments but housed individually. 
 Animals were exposed to handling and left to recover over a five day period. Surgeries 
were completed within 3 days for each experimental group.  
Drugs and Intracerebral Injections 
R-(-)-apomorphine hydrochloride hemihydrate was purchased from Sigma-Aldrich 
Quebec Canada. R-(-)-apomorphine hydrochloride hemihydrate was prepared in a solution 
containing 1% ascorbic acid dissolved in pyrogen-free sterile saline to 3.0 µg/0.3 µl. The 
contents were kept away from light, heat, and air by wrapping it in tin-foil and storing in the 
refrigerator. Carbamylcholine chloride was purchased from Sigma-Aldrich Quebec Canada. 
Carbamycholine chloride was dissolved in a pyrogen-free sterile saline to a dose of to               
1.0 µg/0.3 µl. For control injections a 1% ascorbic acid solution was prepared in a pyrogen-free 
sterile saline.     
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All intracerebral injections were organized in a partly counter balanced manner. The first 
15 rats were used to obtain the dose-response relationship between number of 50-kHz USVs and 
dose of apomorphine injected into the shell of the nucleus accumbens (Table 1). The subsequent 
injection groups were divided into five injection schedules as outlined in Tables 2-5. All 
injections were completed using a Hamilton constant rate syringe (CR-700) and polyethylene 
tubing connected to a 30 gauge stinless steel injection cannula. The total volume of injection was 
0.3 µl per site and a time delay of one minute was given in between double injections before 
recording USVs. The double injections were conducted every 3 days. 
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Table 1: 
Dose Response injection schedule for apomorphine 
Rat I.D Injection 
1 
 
Rat I.D Injection 
2 
Rat ID Injection 
3 
Rat ID Injection 
4 
Rat ID Injection 
5 
 
RMM1 3.0 µg RMM15 3.0 µg RMM11 3.0 µg RMM6 1.0 µg RMM7 2.5 µg 
RMM2 1.0 µg RMM14 0.5 µg RMM10 2.5 µg RMM5 2.5 µg RMM3 1.0 µg 
RMM3 2.5 µg RMM13 2.5 µg RMM9 1.75 µg RMM10 1.0 µg RMM9 0.5 µg 
RMM4 1.75 µg RMM12 3.0 µg RMM12 1.75 µg RMM11 1.0 µg RMM14 1.0 µg 
RMM5 3.0 µg RMM11 1.75 µg RMM13 1.75 µg RMM4 2.5 µg RMM1 2.5 µg 
RMM6 1.75 µg RMM10 0.5 µg RMM14 3.0 µg RMM3 3.0µg RMM6 2.5 µg 
RMM7 1.0 µg RMM9 3.0 µg RMM15 2.5 µg RMM12 1.0 µg RMM2 0.5 µg 
RMM8 0.5 µg RMM8 1.75 µg RMM1 1.0 µg RMM13 1.0 µg RMM11 2.5 µg 
RMM9 2.5 µg RMM7 0.5 µg RMM2 1.75 µg RMM7 3.0 µg RMM10 1.75 µg 
RMM10 3.0 µg RMM6 3.0 µg RMM3 1.75 µg RMM8 1.0 µg RMM4 0.5 µg 
RMM11 0.5 µg RMM5 1.75 µg RMM4 1.0 µg RMM14 1.7.5 µg RMM13 3.0 µg 
RMM12 2.5 µg RMM4 3.0 µg RMM5 1.0 µg RMM15 0.5 µg RMM12 0.5 µg 
RMM13 0.5 µg RMM3 0.5 µg RMM6 0.5 µg RMM9 1.0 µg RMM15 1.75 µg 
RMM14 2.5 µg RMM2 2.5 µg RMM7 1.75 µg RMM1 1.75 µg RMM5 0.5 µg 
RMM15 1.0 µg RMM1 0.5 µg RMM8 2.5 µg RMM2 3.0µg RMM8 3.0 µg 
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Table 2: 
Injection schedule for injection set 1a 
Animal I.D # sal+carb sal+sal apo+carb apo+sal 
Injection 1 Rat 16, 19, 22 Rat 18, 25 Rat  21, 26, 20 Rat  23,17, 24 
Injection 2 Rat  17, 23, 24 Rat 22, 16, 19 Rat 25, 18 Rat  26, 21, 20 
Injection 3 Rat  20, 21, 26 Rat  24, 17, 23 Rat 19, 22, 16 Rat 18, 25 
Injection 4 Rat 25, 18 Rat  26, 20, 21 Rat  23, 24, 17 Rat 16, 22, 19 
 
 
Table 3: 
Injection schedule for injection set 1b 
Animal I.D # sal+carb sal+sal apo+carb apo+sal 
Injection 1 Rat 27, 30, 33 Rat 29, 38, 36 Rat  32, 37, 31 Rat  35, 34, 28 
Injection 2 Rat  28, 34, 35 Rat 33, 27, 30 Rat 36, 29, 38 Rat  37, 32, 31 
Injection 3 Rat  31, 32, 37 Rat  35, 28, 34 Rat 30, 33, 27 Rat 29, 36, 38 
Injection 4 Rat 38, 36, 29 Rat  37, 31, 32 Rat  34, 35, 28 Rat 33, 30, 27 
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Table 4: 
Injection schedule for experiment 2a 
Animal I.D # carb+sal sal+sal carb+apo sal+apo 
Injection 1 Rat 39, 42, 45 Rat 50, 41, 48 Rat  44, 49, 43 Rat  47, 46, 40 
Injection 2 Rat  40, 46, 47 Rat 45 39, 42 Rat 48, 50, 41 Rat  49, 44, 43 
Injection 3 Rat  43, 44, 49 Rat  47, 40, 46 Rat 42, 45, 39 Rat 50, 48, 41 
Injection 4 Rat 41, 48, 50 Rat  49, 43, 44 Rat  46, 47, 40 Rat 45, 39, 42 
 
 
Table 5: 
Injection schedule for experiment 2b 
 
Animal I.D # carb+sal sal+sal carb+apo sal+apo 
Injection 1 Rat 51, 54, 57 Rat 53, 60 Rat  55, 56 Rat  59, 58, 52 
Injection 2 Rat  52, 58, 59 Rat 57, 51, 54 Rat 60, 53 Rat  56, 55 
Injection 3 Rat  55, 56 Rat  59, 52, 58 Rat 55, 57, 51 Rat 53, 60 
Injection 4 Rat 60, 53 Rat  56, 55 Rat  58, 59, 52 Rat 57, 54, 51 
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The four different injection groups 
 After the suitable dose of apomorphine was established to elicit 50-kHz USVs, the rats 
were separated into four different injection set: injection set 1a, 1b and injection set 2a and 2b. 
The first set of injections were to investigate if prior injection of apomorphine into the shell of 
the nucleus accumbens could decrease the number of carbachol induced 22-kHz USVs from the 
AH-MPO (set 1a) or the LS (set 1b). The second sets of injections were to investigate if prior 
injection of carbachol into the AH-MPO or the LS could decrease the number of apomorphine 
induced 50-kHz USVs when injected into the shell of the nucleus accumbens. In all injection 
groups the call parameters across all conditions were quantified in order to confirm the fourth 
prediction. 
Injection set 1a 
This experiment focused on antagonizing carbachol-induced 22-kHz USVs elicited from 
the AH-MPO by prior injection of apomorphine into the medial shell of the nucleus accumbens. 
Order of injections are illustrated in Figure 1. Injection conditions for this group were as follows: 
1) Saline injection into the medial shell of the nucleus accumbens occurred one minute prior to 
injection of carbachol into the AH-MPO (sal+carb). 2) Apomorphine was injected into the 
medial shell of the nucleus accumbens one minute before saline was injected into the AH-MPO 
(apo+sal). 3) Apomorphine was injected into the medial shell of the nucleus accumbens one 
minute before injection of carbachol into the AH-MPO (apo+carb). 4) Saline was injected into 
the shell of the nucleus accumbens one minute prior to injection of saline into the AH-MPO 
(sal+sal). For sequence of injections for each animal see Table 2. 
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Figure 1: Overview of injection set 1a. (A) The parasaggital cross section of the rat brain 
showing both the ascending mesolimbic cholinergic system innervating the medial 
cholinoceptive vocalization strip responsible for the initiation of 22-kHz USVs (black; shaded) 
and the ascending mesolimbic dopamine system  responsible for the initiation of 50-kHz USVs 
(yellow; cross-hatched). (B). Coronal section of the rat brain showing the location of 
apomorphine injection localized into the nucleus accumbens shell (red square). (C). Coronal 
section of the rat brain showing the location of carbachol injection localized to the AH-MPO and 
the location of the second injection (blue square). The injection into the sNa will activate the 
target areas of the ascending mesolimbic dopamine system and the injection into the AH-MPO 
will activate the target areas of the ascending mesolimbic cholinergic system.  
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Injection set 1b 
This series of experiments focused on antagonizing carbachol-induced 22-kHz USVs 
from the lateral septum (LS) by prior injection of apomorphine into the medial shell of the 
nucleus accumbens (Figure 2). The order of injections for this experimental group was as 
follows: 1) Saline was injected into the medial shell of the nucleus accumbens prior to injection 
of carbachol into the LS (sal+carb). 2) Apomorphine was injected into the medial shell of the 
nucleus accumbens prior to injection of saline into the LS (apo+sal). 3). Apomorphine was 
injected into the medial shell of the nucleus accumbens one minute prior to injection of 
carbachol into the LS (apo+carb). 4). Saline injection into the medial shell of the nucleus 
accumbens occurred one minute prior to saline injection into the LS (sal+sal). For injection 
sequence of each animal see Table 3. 
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Figure 2: Overview of injections for experiment set 1b. (A) The parasaggital cross section of the 
rat brain showing both the ascending mesolimbic cholinergic system innervating the medial 
cholinoceptive vocalization strip responsible for the initiation of 22-kHz USVs (black; shaded) 
and the ascending mesolimbic dopamine system  responsible for the initiation of 50-kHz USVs 
(yellow; cross-hatched). (B). Coronal section of the rat brain showing the location of 
apomorphine injection localized into the nucleus accumbens shell (red square). (C). Coronal 
section of the rat brain showing the location of the LS and subsequently the location of carbachol 
to be injected (green square). The injection into the sNa will activate the target areas of the 
ascending mesolimbic dopamine system and the injection into the LS will activate the target 
areas of the ascending mesolimbic cholinergic system 
.  
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Injection set 2a 
This series of experiments focused on antagonizing apomorphine induced 50-kHz USVs 
by prior injection of carbachol into the AH-MPO (Figure 3). Order of injections for this 
experiment was as follows: 1) Carbachol was injected into the AH-MPO one minute prior to 
injection of saline into the medial shell of the nucleus accumbens (carb+sal). 2) Saline injected 
into the AH-MPO occurred one minute prior to injection of apomorphine into the medial shell of 
the nucleus accumbens (sal+apo). 3) Injection of carbachol into the AH-MPO occurred one 
minute prior to injection of apomorphine into the shell of the nucleus accumbens (carb+apo). 4) 
Saline injected into the AH-MPO occurred one minute prior to injection of saline into the medial 
shell of the nucleus accumbens (sal+sal). For overview of animal injection conditions see    
Table 4. 
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Figure 3: Overview of injections set 2a. (A) The parasaggital cross section of a rat brain showing 
both the ascending mesolimbic cholinergic system innervating the medial cholinoceptive 
vocalization strip responsible for the initiation of 22-kHz USVs (black; shaded) and ascending 
mesolimbic dopamine system  responsible for the initiation of 50-kHz USVs (yellow; cross-
hatched). (B). Coronal section of the rat brain showing the location for the first injection of 
carbachol into the AH-MPO (blue square) (C). Coronal section of the rat brain showing the 
location of apomorphine injection into the medial shell of the nucleus accumbens (red square). 
The injection into the AH-MPO will activate the target areas of the ascending mesolimbic 
cholinergic system and the injection into the medial shell of the nucleus accumbens will activate 
the target areas of the ascending mesolimbic dopaminergic system.  
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Injection set 2b 
This series of experiments focused on antagonizing apomorphine induced 50-kHz USVs 
by prior injection of carbachol into the LS (Figure 4). Order of injections for this experiment was 
as follows: 1) Carbachol was injected into the LS one minute prior to injection of saline into the 
medial shell of the nucleus accumbens (carb+sal). 2) Saline injected into the LS occurred one 
minute prior to injection of apomorphine into the medial shell of the nucleus accumbens 
(sal+apo). 3) Carbachol injection into the LS occurred one minute prior to injection of 
apomorphine into the medial shell of the nucleus accumbens (carb+apo). 4). Saline was injected 
into the LS one minute before saline was injected into the medial shell of the nucleus accumbens 
(sal+sal). Animal injection schedules see Table 5.  
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Figure 4: Overview of injections for experiment set 2b. (A) The parasaggital cross section of the 
rat brain showing both the ascending mesolimbic cholinergic system innervating the medial 
cholinoceptive vocalization strip responsible for the initiation of 22-kHz USVs (black; shaded) 
and the ascending mesolimbic dopamine system  responsible for the initiation of 50-kHz USVs 
(yellow; cross-hatched). (B). Coronal section of the rat brain showing the location carbachol 
injection into the LS (green rectangle). (C). Coronal section of the rat brain showing the location 
of the second injection localized to the medial shell of the nucleus accumbens (red square). The 
injection of carbachol into the LS will activate the target areas of the ascending mesolimbic 
cholinergic system and the injection apomorphine into the sNa will activate the target areas of 
the ascending mesolimbic dopaminergic system. 
 
47 
 
Ultrasonic vocalization recording 
Vocalization recording for all groups took place 1 minute after the injection cannula was 
taken out of the brain. All recordings took place in a clean polycarbonate cage (220 mm x 200 x 
190 mm) lined with a single paper towel. The recording chamber was covered with wire lid 
supporting a condenser microphone model CM16/CPA from Avisoft Bioacoustics (Berlin, 
Germany) positioned about 200 mm from the animal. A dishwasher clean cage was given for 
each animal to elimate cross contamination with odors. All recordings were 10 minutes in 
duration with a sampling rate of 200, 000 Hz stored in a 16 bit format using Avisoft Bioacoustics 
system (Avisoft Recorder NI-DAQMX) and subsequently stored on the computer hard drive in 
the analysis room. 
Acoustic Analysis 
 
 All acoustic files were analyzed off-line using Avisoft SASlab Pro program (Avisoft) for 
both 50-kHz and 22-kHz USVs recorded within the first five minutes of the testing session. A 
fast Fourier transformation with a temporal resolution of 488 Hz was used to deconstruct the 
entire 10 minute recording session into its harmonic components allowing the recorded spectral 
parameters of the USVs to be easily visualized and subsequently analyzed. Analysis of 
vocalizations focused on peak frequency (kHz) and duration (ms) of single calls. Calls and their 
subsequent classification were based on a study by Brudzynski (2007). 
Histological procedures 
 After the cycles of injections were finished for each group, animals were sacrificed using 
an over-dose of sodium pentobarbital (240 mg/ml) at 120-150 mg/rat. When the animal was 
deeply anesthetized, the animal was transcardially perfused with 10% formalin solution to fix the 
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brain before extraction. After the brain was extracted and submerged in formalin solution for 48 
hours, they were blocked and mounted on the table of the freezing microtome (Cryo-Histomat) 
with Tissue Tek compound. Brains were sectioned for an approximate 40 µm preparation. After 
sectioning, brains were placed on a polylysine coated microscope slide. The preparations were 
then allowed to dry for approximately 24 hours. 
 After the brain preparations were dried, the sections were stained using the Rucker-
Koithan method, a modified version of the Nissl staining technique (Windle et al, 1943; Skinner, 
1971). Nissl bodies, nuclei and necrotic tissue outlining the cannula and the injection site were 
stained dark blue and non-necrotic tissue in a transparent blue. After staining was complete, 
slides were cover-slipped using Permount glue (Fisher Scientific, Suwanee, GA, USA). Once 
dry, localization of injection sites were mapped using a projection light microscope on matching 
coronal sections of the rat brain from the atlas by Paxinos and Watson (1986).  
Statistical Analysis 
 
  Analyzes of the number of ultrasonic vocalizations were performed with non-parametric 
Friedman’s ANOVA with paired Wilcoxon Signed Ranks post-hoc test. To analyze the duration 
and the peak-frequency of recorded 22-kHz vocalizations, four animals were chosen: one rat 
from injection set 1a, one rat from injection set 1b, one rat from injection set 2a, and one rat from 
injection set 2b. To analyze 22-kHz USVs parameters the first 14 vocalizations (from each 
injection condition) from each rat were chosen then subsequently analyzed. To analyze the 
parameters of 50-kHz USVs (peak-frequency and duration) four animals were chosen, one from 
each of the injection sets. The four animals had the first five 50-kHz USVs analyzed across each 
injection condition while four animals had the first 14 22-kHz USVs analyzed across each 
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injection condition. That means for each injection set, fifty-six (14 USVs x 4 injection 
conditions) 22-kHz USVs were analyzed and twenty (5 USVs x 4 injection conditions) 50-kHz 
USVs were analyzed. All statistical calculations were non-parametric and performed with SPSS 
v 17.0. 
Results 
Dose-response study of apomorphine  
 Localization of injection sites for apomorphine are displayed in Figure 5. Intraaccumbens 
injection of five different doses of apomorphine (0.5 µg, 1.0 µg, 1.75 µg, 2.5 µg, and 3.0 µg) 
revealed an increased number of 50-kHz USVs with increasing doses. Friedman’s ANOVA 
followed by Wilcoxon Test revealed that 3.0 µg of apomorphine significantly increased the 
emissions of flat 50-kHz USVs over 0.5 µg of apomorphine (χ2 [4, 15] = 27. 808, p < .001;        
Z = -2.975, p <. 003; Figure 6). No dose of apomorphine was able to significantly increase the 
number of frequency modulated (FM) vocalizations (χ2 [4, 15] = 8. 065, p > .080; Figure 6). 
Since increasing doses of apomorphine could not increase FM vocalizations, in the remainder of 
the thesis 50-kHz USVs will not be divided into flat or FM vocalizations but counted jointly.  
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Figure 5: Localization for dose-response experiment in the nucleus accumbens: Mapping of 
injection sites for 0.5µg, 1.0 µg, 1.5 µg, 1.75 µg and 3.0 µg of apomorphine. Red triangles 
showed no recorded vocalizations, blue triangles represent injection sites that initiated calls 
between 1-10 50-kHz USVs, and the yellow triangles represent injection sites that initiated calls 
between 11-20 50-kHz USVs.  All rats were injected with all doses of apomorphine and saline. 
Numbers at the top of the diagrams represent frontal planes in mm from the stereotaxic zero. 
Some abbreviations: aca – anterior commusure; mfb – medial forebrain bundle; SHi – 
septohippocampal nucleus; VDB; vertical limb of the diagonal band; LV – lateral ventricle. 
Numbers represent distance from lambda. 
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Figure 6: Dose-response relationship between apomorphine dose and number of 50-kHz USVs 
produced. Apomorphine (Apo) delivered to the medial shell of the nucleus accumbens was able 
to increase the number of flat 50-kHz USVs but was unable to significantly increase frequency 
modulated (FM) 50-kHz USVs. The largest quantity of 50-kHz USVs was induced by 3.0 µg of 
apomorphine.  Error bars represent the S.E.M. 
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Injection group 1 a: Can injection of apomorphine into the medial shell of the nucleus 
accumbens, prior to injection of carbachol into the AH-MPO, decrease the number of emitted 
22-kHz USVs? 
 22-kHz USVs: Localization of injection sites for injection group 1a are displayed in 
Figure 7 and 8. Injection of apomorphine into the medial shell of the nucleus accumbens one 
minute prior to injection of carbachol into the AH-MPO (apo+carb) significantly reduced the 
number of emitted 22-kHz USVs compared to USVs emitted after the saline-carbachol 
(sal+carb) injection (χ2 [3, 11] = 33. 000, p < .001; Z = -2.934, p < . 001; Figure 9). Analysis of 
call parameters did show significant differences. Injection of apomorphine into the medial shell 
of the nucleus accumbens before injection of carbachol into the AH-MPO significantly reduced 
the duration of 22-kHz USVs (χ2 [3, 56] = 151.76, p < .001; Z = -3.997, p < .001; Figure 10). 
Apomorphine was unable to alter the peak frequency of 22-kHz USVs when compared to 
sal+carb injection conditions (χ2 [3, 56] = 164.4, p < .001; Z = -1.313, p = .130; Figure 11). 
 50-kHz USVs: Injection of apomorphine into the shell of the nucleus accumbens and 
saline into the AH-MPO (apo+sal) significantly increased the number of 50-kHz USVs over 
sal+carb (χ2 [3, 11] = 21. 835, p =. 000; Z = -2. 851, p = .004; Figure 12) conditions. Injection of 
apomorphine and carbachol (apo+carb) significantly attenuated the emission of 50-kHz USVs 
compared to apomorphine saline injections (apo+sal; Z = -2.941, p = .003; Figure 12). Injection 
of carbachol into the AH-MPO, after injection of apomorphine into the medial shell of the 
nucleus accumbens, was unable to alter the duration (χ2 [3, 20] = .294 p = .961; Figure 13) or 
peak frequency (χ2 [3, 20] = 2.700, p =.440; Figure 14) of 50-kHz USVs. 
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Figure 7: Mapping of injection sites (triangles) for 3.0 µg of apomorphine injected into the shell 
of the nucleus accumbens. The triangles are colour coded for the magnitude of the response. 
Blue triangles elicited a response between 1-10 50-kHz USVs, dark blue triangles elicited 
between 11-20 50-kHz USVs and the green triangles elicited between 21-30 50-kHz USVs. 
Numbers at the top of the diagrams represent frontal planes in mm from the stereotaxic zero. For 
abbreviations see Figure 5. 
54 
 
.  
Figure 8: Mapping of injection sites (circles) for 1.0 µg of carbachol injected into the AH-MPO. 
The circles are colour coded for the magnitude of the response. Red circles elicited between 0-
100 22-kHz USVs, yellow circles elicited between 101-200 22-kHz USVs and the purple circles 
elicited between 201-300 22-kHz USVs. Numbers at the top of the diagrams represent frontal 
planes in mm from the stereotaxic zero. Selected abbreviations: AHP- anterior hypothalamic 
area; sm – stria medullaris.  
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Figure 9:  Mean number of 22-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to injection 
of carbachol (carb) into the AH-MPO, was able to significantly reduce the mean number of 
recorded 22-kHz USVs. Injection conditions were as follows : sal+carb – saline injected into the 
sNa and carbachol injected into AH-MPO; apo+sal – apomorphine injected into the sNa and 
saline injected into the AH-MPO; apo+carb – apomorphine into the sNA and carbachol into AH-
MPO; sal+sal – saline injected into the sNa and saline injected into the AH-MPO 
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Figure 10: Mean duration (± S.E.M.) of recorded 22-kHz USVs. The x-axis represents the 
various injection conditions and the y-axis represents the mean duration of 22-kHz USVs 
emitted. Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, one 
minute prior to injection of carbachol (carb) into the AH-MPO, was able to significantly alter the 
duration of the 22-kHz USVs. Injection conditions were as follows: sal+carb – saline injected 
into the sNa and carbachol injected into AH-MPO; apo+sal – apomorphine injected into the sNa 
and saline injected into the AH-MPO; apo+carb – apomorphine into the sNA and carbachol into 
AH-MPO; sal+sal – saline injected into the sNa and saline injected into the AH-MPO. 
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Figure 11: Mean peak frequency (± S.E.M.) of recorded 22-kHz USVs under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean peak frequency of 22-kHz USVs emitted. Injection 
of apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to 
injection of carbachol (carb) into the AH-MPO, was unable to alter the peak frequency of the 22-
kHz USVs. Injection conditions were as follows : sal+carb – saline injected into the sNa and 
carbachol injected into AH-MPO; apo+sal – apomorphine injected into the sNa and saline 
injected into the AH-MPO; apo+carb – apomorphine into the sNA and carbachol into AH-MPO; 
sal+sal – saline injected into the sNa and saline injected into the AH-MPO. 
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Figure 12: Mean number of 50-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 50-kHz USVs emitted. Injection of 
carbachol (carb) into the AH-MPO, one minute after injection of apomorphine (apo) into the 
shell, was able to significantly reduce the mean number of 50-kHz USVs.  Injection conditions 
were as follows: sal+carb – saline injected into the sNa and carbachol injected into AH-MPO; 
apo+sal – apomorphine injected into the sNa and saline injected into the AH-MPO; apo+carb – 
apomorphine into the sNA and carbachol into AH-MPO; sal+sal – saline injected into the sNa 
and saline injected into the AH-MPO. 
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Figure 13: Mean duration of recorded 50-kHz USVs (±S. E. M.). The x-axis represents the 
various injection conditions and the y-axis represents the mean duration of 50-kHz USVs 
emitted. Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, one 
minute prior to injection of carbachol (carb) into the AH-MPO, was unable to significantly 
change the duration of 50-kHz USVs USVs. Injection conditions were as follows: sal+carb – 
saline injected into the sNa and carbachol injected into AH-MPO; apo+sal – apomorphine 
injected into the sNa and saline injected into the AH-MPO; apo+carb – apomorphine into the 
sNA and carbachol into AH-MPO; sal+sal – saline injected into the sNa and saline injected into 
the AH-MPO. 
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Figure 14: Mean peak frequency (±S. E. M.) of recorded 50-kHz USVs recorded under different 
injection conditions during a five minute recording session. The x-axis represents the various 
injection conditions and the y-axis represents the mean value of peak frequency in kHz. Injection 
of apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to 
injection of carbachol (carb) into the AH-MPO, was unable to significantly change the mean 
peak frequency of 50-kHz USVs USVs. Injection conditions were as follows: sal+carb – saline 
injected into the sNa and carbachol injected into AH-MPO; apo+sal – apomorphine injected into 
the sNa and saline injected into the AH-MPO; apo+carb – apomorphine into the sNA and 
carbachol into AH-MPO; sal+sal – saline injected into the sNa and saline injected into the AH-
MPO. 
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Injection set 1b: Can injection of apomorphine into the medial shell of the nucleus accumbens, 
prior to injection of carbachol into the LS, decrease the number of emitted 22-kHz USVs? 
22-kHz USVS: Localization of injection sites for injection set 1b can be found in Figures 
15 and 16. Injection of apomorphine into the medial shell of the nucleus accumbens one minute 
prior to injection of carbachol into the LS (apo+carb) significantly reduced the number of 
emitted 22-kHz USVs compared to the saline-carbachol (sal+carb) condition  (χ2 [3, 12] = 
24.926, p = .000; Z= -2.075, p = .038; Figure 17). Analysis of call parameters also showed 
significant differences in the duration of 22-kHz USVs during the apo+carb condition compared 
to the sal+carb condition (χ2 [3, 56] = 147. 3, p < .001; Z = -2. 304; p = .021; Figure 18) but the 
peak frequency of 22-kHz USVs remained unchanged (χ2 [3, 56] = 151. 3, p < .001; Z = -1.44,   
p = .150; Figure 19).  
 50-kHz USVs: Apomorphine injected into the medial shell of the nucleus accumbens 
prior to saline injection into the LS (apo+sal) significantly increased the number of 50-kHz 
USVs compared to sal+sal injections (χ2 [3, 12] = 20. 357, p =.000; Z = -2.688, p =.008; Figure 
20) and saline-carbachol injections (Z = -2.312, p =.012; Figure 20). Injection of apomorphine 
into the medial shell of the nucleus accumbens, prior to injection of carbachol into the LS, 
significantly reduced the number of emitted 50-kHz USVs when compared to apo+sal injection 
(Z = -2.429, p = .015; Figure 20). Injection of carbachol into the LS, after injection of 
apomorphine into the medial shell of the nucleus accumbens, was unable to alter the duration (χ2 
[3, 20] = 1.275, p >.05; Figure 21) or the peak frequency (χ2 [3, 20] =2.508, p >.05; Figure 22) of 
recorded 50-kHz USVs.    
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Figure 15: Mapping of injection sites (triangles) for 3.0 µg of apomorphine injected into the 
nucleus accumbens shell. The triangles are colour coded for the magnitude of the response. Red 
triangles elicited a response between 1-10 50-kHz USVs, the dark blue triangle elicited between 
11-20 50-kHz USVs and the yellow triangles elicited between 21-30 50-kHz USVs. Numbers at 
the top of the diagrams represent frontal planes in mm from the stereotaxic zero. For 
abbreviations see Figure 5. 
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Figure 16: Mapping of injection sites for 1.0 µg of carbachol from the lateral septum. The stars 
are colour coded for the magnitude of the response.  Blue stars elicited 0 – 10 22-kHz USVs, 
yellow stars elicited 101-200 USVs and purple stars were able to elicit between 201-300 22-kHz 
USVs. Numbers at the top of the diagrams represent frontal planes in mm from the stereotaxic 
zero. Selected abbreviations: LV = Lateral Ventricle; LS = Lateral Septum; cc = corpus 
callosum; f- fornix.  
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Figure 17: Mean number of 22-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to injection 
of carbachol (carb) into the LS, was able to significantly reduce the mean number of recorded 
22-kHz USVs as compared to the sal+carb condition. Injection conditions were as follows: 
sal+carb – saline injected into the sNa and carbachol injected into LS; apo+sal – apomorphine 
injected into the sNa and saline injected into the LS; apo+carb – apomorphine into the sNA and 
carbachol into LS; sal+sal – saline injected into the sNa and saline injected into the LS. 
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Figure 18: Mean duration (± S. E.M.) of the recorded 22-kHz USVs. The x-axis represents the 
various injection conditions and the y-axis represents the mean duration (ms) of 22-kHz USVs 
emitted. Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, one 
minute prior to injection of carbachol (carb) into the LS, was able to significantly alter the 
duration (ms) of the 22-kHz USVs. Injection conditions were as follows: sal+carb – saline 
injected into the sNa and carbachol injected into LS; apo+sal – apomorphine injected into the 
sNa and saline injected into the LS; apo+carb – apomorphine into the sNA and carbachol into 
LS; sal+sal – saline injected into the sNa and saline injected into the LS. 
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Figure 19: Mean peak frequency of 22-kHz USVs (± S.E.M.) under different injection conditions 
during a five minute recording session. The x-axis represents the various injection conditions and 
the y-axis represents the mean peak frequency of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to injection 
of carbachol (carb) into the LS, was unable to alter the peak frequency of the 22-kHz USVs. 
Injection conditions were as follows: sal+carb – saline injected into the sNa and carbachol 
injected into LS; apo+sal – apomorphine injected into the sNa and saline injected into the LS; 
apo+carb – apomorphine into the sNA and carbachol into LS; sal+sal – saline injected into the 
sNa and saline injected into the LS. 
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Figure 20: Mean number of 50-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 50-kHz USVs emitted. Apo+sal 
conditions showed a significant increase in emission of 50-kHz USVs compared to sal+sal and 
sal+carb conditions. Injection of carbachol (carb), one minute after an injection of apomorphine 
(apo) into the shell of the accumbens significantly reduced the mean number of 50-kHz USVs. 
Injection conditions were as follows: sal+carb – saline injected into the sNa and carbachol 
injected into LS; apo+sal – apomorphine injected into the sNa and saline injected into the LS; 
apo+carb – apomorphine into the sNA and carbachol into LS; sal+sal – saline injected into the 
sNa and saline injected into the LS. 
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Figure 21: Mean duration (ms) of 50-kHz USVs (±S.E.M.). The x-axis represents the various 
injection conditions and the y-axis represents the mean duration of 50-kHz USVs emitted. 
Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior 
to injection of carbachol (carb) into the LS, was unable to significantly change the duration of 
50-kHz USVs. Calls in all conditions had comparable durations. Injection conditions were as 
follows: sal+carb – saline injected into the sNa and carbachol injected into LS; apo+sal – 
apomorphine injected into the sNa and saline injected into the LS; apo+carb – apomorphine into 
the sNA and carbachol into LS; sal+sal – saline injected into the sNa and saline injected into the 
LS. 
0
5
10
15
20
25
30
35
40
45
50
sal+carb apo+sal apo+carb sal+sal
D
ur
at
io
n 
(m
s)
Injection Condition
69 
 
 
Figure 22: Mean peak frequency (± S.E.M.) of 50-kHz USVs under different injection conditions 
during a five minute recording session. The x-axis represents the various injection conditions and 
the y-axis represents the mean peak frequency of 50-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute prior to injection 
of carbachol (carb) into the LS, was unable to significantly change the mean peak frequency of 
50-kHz USVs. Calls in all conditions had comparable peak frequencies. Injection conditions 
were as follows: sal+carb – saline injected into the sNa and carbachol injected into LS; apo+sal – 
apomorphine injected into the sNa and saline injected into the LS; apo+carb – apomorphine into 
the sNA and carbachol into LS; sal+sal – saline injected into the sNa and saline injected into the 
LS. 
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Injection set 2a: Can carbachol injected into the AH-MPO, prior to apomorphine injection into 
the shell of the nucleus accumbens, decrease the number of emitted 50-kHz USVs? 
50-kHz USVS: Localizations for this injection set can be found in Figure 23 and 24. 
Injection of carbachol into the AH-MPO one minute prior to injection of apomorphine into the 
medial shell of the nucleus accumbens was unable to significantly reduce the number of recorded 
50-kHz USVs (χ2 [3, 12] = 12.207, p < .005; Z = -1.844, p = .066; Figure 25). The sal+apo 
condition was able to significantly increase the number of emitted 50-kHz USVs compared to 
sal+sal injection (Z = - 2.201, p = .021; Figure 25) while the carb+apo condition showed no 
significant difference in facilitating the production of 50-kHz USVs compared to sal+sal 
condition (Z = -1. 841, p = .198; Figure 25). The differential USV responses that the sal+apo and 
carb+apo injection conditions produced suggests that injection of carbachol into the AH-MPO 
showed a trend in reducing the number of apomorphine induced 50-kHz USVs. Injection of 
carbachol into the AH-MPO prior to injection of apomorphine was unable to alter both the 
duration (χ2 [3, 20] = 3.34, p > .05; Figure 26) and peak frequency (χ2 [3, 20] = 2.201, p >. 05; 
Figure 27) of recorded 50-kHz USVs.  
22-kHz USVS: Injection of carbachol followed by saline induced a high number of 22-
kHz USVs (Figure 28). Injection of apomorphine into the medial shell of the nucleus accumbens 
after carbachol was able to reduce the mean number of recorded 22-kHz USVs (carb+apo) 
compared to carbachol-saline injections (χ2 [3, 12] = 17.118; p = .001; Z = -2.201, p = .038; 
Figure 28). Analysis of recorded 22-kHz USVs showed that apomorphine was also able to 
reduce the mean duration of 22-kHz USVs compared to controls (carb+sal) injections (χ2 [3, 56] 
= 156.172, p < .001; Z = -5.422, p < .001; Figure 29) but was unable to alter the peak frequency 
of recorded 22-kHz USVs (χ2 [3, 56] = 147. 331, p < .001; Z = .216, p > .05; Figure 30). 
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Figure 23: Mapping of injection sites (circles) for 1.0 µg of carbachol in the AH-MPO. The 
circle localizations are colour coded for the number of the 22-kHz USVs. Blue circles were able 
to elicit between 0-100 22-kHz USVs, yellow circles were able to elicit between 100-200 22-kHz 
USVs and purple circles were able to elicit between 201-300 22-kHz USVs. The numbers at the 
top of the diagrams represent frontal planes in mm from the stereotaxic zero. For selected 
abbreviations see Figure 8.  
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Figure 24: Mapping of localization sites (triangles) for 3.0 µg of apomorphine injected into the 
shell of the nucleus accumbens. The localization triangles are colour coded for the magnitude of 
the response. Red triangles were able to induce 1-10 50-kHz USVs, blue triangles were able to 
induce 11-20 50-kHz USVs and yellow triangles were able to elicit 21-45 50-kHz USVs. The 
numbers at the top of the diagrams represent frontal planes in mm from the stereotaxic zero. For 
selected abbreviations see Figure 1.  
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Figure 25: Mean number of 50-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 50-kHz USVs emitted. Injection of 
carbachol (carb) into the AH-MPO, one minute before an injection of apomorphine (apo) into the 
nucleus accumbens, significantly reduced the mean number of recorded 50-kHz USVs. Injection 
conditions were as follows: carb+sal – carbachol was injected into the AH-MPO and saline was 
injected into the medial shell of the nucleus accumbens; sal+apo – saline was injected into the 
AH-MPO and apomorphine was injected into the medial shell of the nucleus accumbens; 
carb+apo – carbachol was injected into the AH-MPO and apomorphine was injected into the 
medial shell of the nucleus accumbens; sal+sal – saline was injected into the AH-MPO and 
saline was injected into the medial shell of the nucleus accumbens. 
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Figure 26: Mean duration (± S.E.M.) of 50-kHz USVs. The x-axis represents the various 
injection conditions and the y-axis represents the mean duration of 50-kHz USVs emitted. 
Injection of apomorphine into the medial shell of the nucleus accumbens, one minute after an 
injection of carbachol into the AH-MPO, was unable to significantly change the duration of 50-
kHz USVs USVs Injection conditions were as follows: carb+sal – carbachol was injected into the 
AH-MPO and saline was injected into the medial shell o the nucleus accumbens; sal+apo – 
saline was injected into the AH-MPO and apomorphine was injected into the medial shell of the 
nucleus accumbens; carb+apo – carbachol was injected into the AH-MPO and apomorphine was 
injected into the medial shell of the nucleus accumbens; sal+sal – saline was injected into the 
AH-MPO and saline was injected into the medial shell of the nucleus accumbens. 
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Figure 27: Mean peak frequency (± S.E.M.) of 50-kHz USVs under different injection conditions 
during a five minute recording session. The x-axis represents the various injection conditions and 
the y-axis represents the mean peak frequency of 50-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an injection 
of carbachol (carb) into the AH-MPO, was unable to significantly change the mean peak 
frequency of 50-kHz USVs USVs Injection conditions were as follows: carb+sal – carbachol was 
injected into the AH-MPO and saline was injected into the medial shell o the nucleus 
accumbens; sal+apo – saline was injected into the AH-MPO and apomorphine was injected into 
the medial shell of the nucleus accumbens; carb+apo – carbachol was injected into the AH-MPO 
and apomorphine was injected into the medial shell of the nucleus accumbens; sal+sal – saline 
was injected into the AH-MPO and saline was injected into the medial shell of the nucleus 
accumbens. 
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Figure 28: Mean number of 22-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an injection 
of carbachol (carb) into the AH-MPO, was able to significantly reduce the mean number of 
recorded 22-kHz USVs. Injection conditions were as follows: carb+sal – carbachol was injected 
into the AH-MPO and saline was injected into the medial shell o the nucleus accumbens; sal+apo 
– saline was injected into the AH-MPO and apomorphine was injected into the medial shell of 
the nucleus accumbens; carb+apo – carbachol was injected into the AH-MPO and apomorphine 
was injected into the medial shell of the nucleus accumbens; sal+sal – saline was injected into 
the AH-MPO and saline was injected into the medial shell of the nucleus accumbens. 
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Figure 29: Mean duration (±S.E.M.) of the same 22-kHz USVs in figure 22. The x-axis 
represents the various injection conditions and the y-axis represents the mean duration of 22-kHz 
USVs emitted. Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, 
one minute prior to injection of carbachol (carb) into the AH-MPO, was able to significantly 
alter the duration of the 22-kHz USVs. Injection conditions were as follows: carb+sal – 
carbachol was injected into the AH-MPO and saline was injected into the medial shell o the 
nucleus accumbens; sal+apo – saline was injected into the AH-MPO and apomorphine was 
injected into the medial shell of the nucleus accumbens; carb+apo – carbachol was injected into 
the AH-MPO and apomorphine was injected into the medial shell of the nucleus accumbens; 
sal+sal – saline was injected into the AH-MPO and saline was injected into the medial shell of 
the nucleus accumbens. 
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Figure 30: Mean peak frequency (±S.E.M.) of 22-kHz USVs under different injection conditions 
during a five minute recording session. The x-axis represents the various injection conditions and 
the y-axis represents the mean peak frequency of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an injection 
of carbachol (carb) into the AH-MPO, was unable to alter the peak frequency of the 22-kHz 
USVs. Injection conditions were as follows: carb+sal – carbachol was injected into the AH-MPO 
and saline was injected into the medial shell o the nucleus accumbens; sal+apo – saline was 
injected into the AH-MPO and apomorphine was injected into the medial shell of the nucleus 
accumbens; carb+apo – carbachol was injected into the AH-MPO and apomorphine was injected 
into the medial shell of the nucleus accumbens; sal+sal – saline was injected into the AH-MPO 
and saline was injected into the medial shell of the nucleus accumbens. 
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Injection set 2b: Can carbachol injected into the LS, prior to injection of apomorphine into the 
medial shell of the nucleus accumbens, decrease the number of emitted 50-kHz USVs?  
50-kHz USVS: Localization of injections for injection set 2b can be found in Figures 31 
and 32. Injection of carbachol into the LS one minute before injection of apomorphine into the 
medial shell of the nucleus accumbens (carb+apo) significantly reduced the mean number of 
emitted 50-kHz USVs compared to the saline-apomorphine (sal+apo) condition (χ2 [3, 10] = 
13.500, p = .004; Z = -2.205, p = .028; Figure 33). The carbachol-apomorphine (carb+apo) was 
not significantly different from the saline-saline condition to in production of 50-kHz USVs (Z = 
1.620, p > .05; Figure 33). Injection of carbachol prior to injection of apomorphine was unable to 
alter the duration (χ2 [3, 20] = 1.708, p = .463; Figure 34) or the peak frequency (χ2 = [3, 20] = 2. 
563, p = .653; Figure 35) of 50-kHz USVs.  
22-kHz USVS: Injection of carbachol into the LS followed by saline injection into the 
shell of the nucleus accumbens induced a high number of 22-kHz calls (Figure 36). Injection of 
apomorphine into the medial shell of the nucleus accumbens after carbachol injection into the LS 
significantly reduced the mean number of 22-kHz USVs compared to carb+sal injection 
condition (χ2 [3, 10] = 22.833, p < .001; Z = -2.032, p = .042; Figure 36). Analysis of 22-kHz 
USVs showed that injection of apomorphine into the medial shell of the nucleus accumbens, 
after carbachol was injected into the LS, significantly reduced the duration of emitted 22-kHz 
USVs (χ2 [3, 56] = 158.9, p = .000; Z = -5.672, p < .001; Figure 37) but did not change the peak 
frequency (χ2 [3, 56] = 132.08, p = .001; Z = -1.160, p = .246; Figure 38) 
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Figure 31: Mapping of injection sites for 1.0 µg of carbachol injected into the LS. The stars are 
colour coded for the number of 22-kHz USVs. Blue stars were able to initiate 0 22-kHz USVs, 
yellow stars were able to initiate 100-200 22-kHz USVs, and purple stars were able to initiate 
201-300 22-kHz USVs. The numbers at the top of the diagrams represent frontal planes in mm 
from the stereotaxic zero. Selected abbreviations see Figure 12b. 
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Figure 32: Mapping of injection sites for 3.0 µg of apomorphine injected into the shell of the 
nucleus accumbens. The localization triangles are colour coded for the magnitude of the 
response. Red circles were able to induce 0 50-kHz USVs, blue triangles were able to elicit 1-10 
50-kHz USVs and yellow triangles were able to elicit 10-20 50-kHz USVs. The numbers at the 
top of the diagrams represent frontal planes in mm from the stereotaxic zero. For selected 
abbreviations see Figure 1.  
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Figure 33: Mean number of 50-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 50-kHz USVs emitted. Injection of 
carbachol (carb) into the LS, one minute before an injection of apomorphine (apo) into the 
medial nucleus accumbens, was able to significantly reduce the mean number of 50-kHz USVs. 
Injection conditions were as follows: carb+sal – carbachol was injected into the LS and saline 
was injected into the medial shell of the nucleus accumbens; sal+apo – saline was injected into 
the LS and apomorphine was injected into the medial shell of the nucleus accumbens;    
carb+apo – carbachol was injected into the LS and apomorphine was injected into the medial 
shell of the nucleus accumbens; sal+sal – saline was injected into the LS and saline was injected 
into the medial shell of the nucleus accumbens. 
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Figure 34: Mean duration (± S.E.M.) of the same vocalizations analyzed in figure 33. The x-axis 
represents the various injection conditions and the y-axis represents the mean duration (ms) of 
50-kHz USVs emitted. Injection of apomorphine into the medial shell of the nucleus accumbens, 
one minute after an injection of carbachol into the LS, was unable to significantly change the 
duration of 50-kHz USVs USVs. Injection conditions were as follows Injection conditions were 
as follows: carb+sal – carbachol was injected into the LS and saline was injected into the medial 
shell of the nucleus accumbens; sal+apo – saline was injected into the LS and apomorphine was 
injected into the medial shell of the nucleus accumbens; carb+apo – carbachol was injected into 
the LS and apomorphine was injected into the medial shell of the nucleus accumbens; sal+sal – 
saline was injected into the LS and saline was injected into the medial shell of the nucleus 
accumbens. 
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Figure 35: Mean peak frequency (± S.E.M.) of 50-kHz USVs recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean peak frequency of 50-kHz USVs emitted. Injection 
of apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an 
injection of carbachol (carb) into the LS, was unable to significantly change the mean peak 
frequency of 50-kHz USVs USVs. Injection conditions were as follows Injection conditions 
were as follows: carb+sal – carbachol was injected into the LS and saline was injected into the 
medial shell of the nucleus accumbens; sal+apo – saline was injected into the LS and 
apomorphine was injected into the medial shell of the nucleus accumbens; carb+apo – carbachol 
was injected into the LS and apomorphine was injected into the medial shell of the nucleus 
accumbens; sal+sal – saline was injected into the LS and saline was injected into the medial shell 
of the nucleus accumbens. 
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Figure 36: Mean number of 22-kHz USVs (± S.E.M.) recorded under different injection 
conditions during a five minute recording session. The x-axis represents the various injection 
conditions and the y-axis represents the mean number of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an injection 
of carbachol (carb) into the LS, was able to significantly reduce the mean number of recorded 
22-kHz USVs. Injection conditions were as follows Injection conditions were as follows: 
carb+sal – carbachol was injected into the LS and saline was injected into the medial shell of the 
nucleus accumbens; sal+apo – saline was injected into the LS and apomorphine was injected into 
the medial shell of the nucleus accumbens; carb+apo – carbachol was injected into the LS and 
apomorphine was injected into the medial shell of the nucleus accumbens; sal+sal – saline was 
injected into the LS and saline was injected into the medial shell of the nucleus accumbens. 
 
 
 
0
20
40
60
80
100
120
carb+sal sal+apo carb+apo sal+sal
M
ea
n 
nu
m
be
r 
of
 2
2-
kH
z 
U
SV
s
Injection Condition
p= .042 
86 
 
 
Figure 37: Mean duration (± S.E.M.) of the same vocalizations analyzed in figure 36. The x-axis 
represents the various injection conditions and the y-axis represents the mean duration of 22-kHz 
USVs emitted. Injection of apomorphine (apo) into the medial shell of the nucleus accumbens, 
one minute after an injection of carbachol (carb) into the LS, was able to significantly alter the 
duration of the 22-kHz USVs. Injection conditions were as follows Injection conditions were as 
follows: carb+sal – carbachol was injected into the LS and saline was injected into the medial 
shell of the nucleus accumbens; sal+apo – saline was injected into the LS and apomorphine was 
injected into the medial shell of the nucleus accumbens; carb+apo – carbachol was injected into 
the LS and apomorphine was injected into the medial shell of the nucleus accumbens; sal+sal – 
saline was injected into the LS and saline was injected into the medial shell of the nucleus 
accumbens. 
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Figure 38: Mean peak frequency (± S.E.M.) of 22-kHz USVs under different injection conditions 
during a five minute recording session. The x-axis represents the various injection conditions and 
the y-axis represents the mean peak frequency of 22-kHz USVs emitted. Injection of 
apomorphine (apo) into the medial shell of the nucleus accumbens, one minute after an injection 
of carbachol (carb) into the LS, was unable to alter the PF of the 22-kHz USVs. Injection 
conditions were as follows Injection conditions were as follows: carb+sal – carbachol was 
injected into the LS and saline was injected into the medial shell o the nucleus accumbens; sal-
apo – saline was injected into the LS and apomorphine was injected into the medial shell of the 
nucleus accumbens; carb+apo – carbachol was injected into the LS and apomorphine was 
injected into the medial shell of the nucleus accumbens; sal+sal – saline was injected into the LS 
and saline was injected into the medial shell of the nucleus accumbens. 
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Discussion 
 The goal of this thesis was to provide evidence of the functional relationship between the 
ascending mesolimbic dopamine system and the ascending mesolimbic cholinergic system and to 
describe the relationship between the two systems. Four predictions were formulated from the 
hypothesis. The first prediction stated that apomorphine will dose-dependently increase the 
number of 50-kHz USVs since this category of USVs are dependent on dopamine transmission 
in the shell of the accumbens, the 2nd and 3rd prediction focused on the reduction in aversive or 
appetitive USVs upon activation of the opposing emotional system, and the 4th prediction stated 
the parameters of the USVs would not change because they are instrumental in conveying the 
message.  
Evaluating the first prediction: Apomorphine’s ability to increase the emission of 50-kHz USVs 
 The doses of apomorphine that were used to establish a relationship between 
apomorphine dose and production of 50-kHz USVs were 0.5 μg, 1.0 μg, 1.75 μg, 2.5 μg and 3.0 
μg. The high doses of apomorphine, but not the low doses, were able to increase the production 
of 50-kHz USVs which is consistent with the biphasic pharmacological profile of apomorphine 
action (Di Chiara et al., 1976). Low doses of apomorphine have been reported to inhibit 
dopamine cell firing, decrease dopamine metabolism, inhibit dopamine release, decrease 
locomotor activity in rats and increase yawning in rats (Lynch, 1991). High doses of 
apomorphine have been reported to cause the opposite physiological and behavioural changes 
compared to low doses of apomorphine including, but not limited to, increased dopamine 
metabolism, increased locomotor activity, increased gnawing compulsion, and increased 
dopamine cell firing (Lynch, 1991). The dose-response relationship of apomorphine induced 50-
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kHz USVs is consistent with the literature describing apomorphine’s pharmacological behaviour. 
Injection of 0.5 μg and 1.0 μg caused the lowest mean number of 50-kHz USVs while 3.0 μg 
caused the largest increase in emitted 50-kHz USVs. However, apomorphine was only able to 
increase the number of flat 50-kHz USVs and did not significantly increase the number of FM 
50-kHz USVs. 
 Emerging evidence suggests the FM 50-kHz USVs are dependent upon activation of D3 
receptors. Brudzynski and colleagues reported that injection of low doses of quinpirole, a 
selective D2/D3 agonist, was able to increase the number of FM vocalizations over amphetamine, 
a drug that increases synaptic concentration of dopamine. Increases in FM 50-kHz USVs by 
quinpirole were selectively attenuated by pretreatment of the shell of the nucleus accumbens 
with U-991941, a selective D3 receptor antagonist (Brudzynski, et al, 2012). Although the 
precise mechanism that causes an increase in FM 50-kHz USVs after activation of D3 receptors is 
unknown, it does explain why there was a failure of apomorphine to increase FM 50-kHz USVs 
since apomorphine has been reported to be predominantly a D1/D2 receptor agonist.  
Evaluating predictions 2 and 3: The relationship between the two emotional systems is 
antagonistic in nature 
 Activation of the mesolimbic dopamine system prior to activation of the ascending 
mesolimbic cholinergic system was able to reduce the number of 22-kHz USVs. Conversely, 
activation of the ascending mesolimbic cholinergic system before activation of the mesolimbic 
dopaminergic system was able to decrease 50-kHz USVs. This decrease in both appetitive and 
aversive USVs by prior activation of the opposing system provides evidence that the two systems 
interact with each other and the nature of their interaction is antagonistic. This answers the 
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central question of the thesis and satisfies the main goal. However, a problem with the central 
hypothesis does arise since the mechanism of interaction predicts the absence of vocalization 
during the activation of both emotional systems, since they are antagonistic to each other. This 
was not demonstrated. Both 50-kHz and 22-kHz USVs were recorded after activation of the 
opposing emotional system. This raises the possibility that the two systems are not directly 
antagonistic along the neuraxis of the rat, but rather there exist brain nuclei that are able to toggle 
the activation of one emotional system over another.  
 If such brain nuclei exist that help mediate the activation of one system over another then 
these brain nuclei should be activated during aversive or appetitive conditions which would 
increase the release of acetylcholine into the terminal fields of the medial cholinoceptive 
vocalization strip or increase the release of dopamine into the shell of the nucleus accumbens, 
respectively.  One potential nucleus that satisfies such criteria is the LTDg.   
LTDg-VTA connection: Increasing dopamine within the nucleus accumbens during reward 
 Tracing studies coupling lectin tracers with immunocytochemical detection has revealed 
that the LTDg projects heavily to both medial and ventral sections of the VTA (Cornwall et al, 
1990) using glutamate, acetylcholine and GABA releasing neurons. Although the exact 
physiology and function of the LTDg-VTA projection is complex, it has been reported that both 
glutamate and acetylcholine projections onto dopamine containing neurons in the VTA are able 
to indirectly increase the release of dopamine within the nucleus accumbens (Forester and Blaha, 
2000; Forester et al, 2001). Using chronoamperometry, Forester and Blaha (2000) reported that 
electrical stimulation of the LTDg caused an increase in dopamine oxidation current measured in 
the shell of the nucleus accumbens. The increase in dopamine oxidation current is dependent 
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upon both glutamatergic and cholinergic from the LTDg since intra-VTA infusion of 
mecamylamine, a nicotinic antagonist and kynurenate, a glutamatergic antagonist, blocked the 
increase in dopamine oxidation current in response to LTDg stimulation. It has also been 
reported that the m5 muscarinic receptor also contributes to the prolonged release of dopamine 
within the nucleus accumbens during reward (Forester et al, 2001). Yeomans and colleagues 
(2001) reported the increases in dopamine release into the nucleus accumbens after rewarding 
electrical stimulation of the lateral hypothalamus, a condition that has been reported to increase 
50-kHz USVs in rats, can be decreased in rats with truncated m5 receptors being expressed on 
dopamine cell bodies in the VTA (Yeomans et al, 2001) of mice. Cholinergic innervation of 
dopamine neurons that expressed the m5 receptor was provided by the LTDg (Yeomans et al, 
2001). Innervation of the VTA by the LTDg is involved with the release of dopamine into the 
nucleus accumbens, but it is also involved in changing the firing activity of dopamine neurons 
from irregular to phasic.  
Dopamine neurons within the VTA display two types of firing properties. Under basal 
situations dopamine cell bodies fire in an irregular and uncoordinated manner, but under 
conditions that are considered to be rewarding, the dopamine cells change their firing patterns 
from irregular to phasic (Mileykovskiy and Morales, 2011; Mirenowicz and Schultaz, 1996). 
This phasic firing pattern of dopamine is able to increase the release of dopamine through the 
mesolimbic dopamine system, especially the shell of the nucleus accumbens (Ikemoto, 2007; 
Matsumoto and Hikosaka, 2007; Matsumoto and Hikosaka, 2000). This change in dopamine 
firing activity from irregular to phasic does partially depends on the glutamatergic input from the 
LTDg. Support of this relationship is demonstrated by intra-VTA injections of AMPA 
antagonists, such as (±)-2-amino-5-phosphonopentanoic acid, which can block the ability of 
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dopamine neurons to transition from irregular to rhythmic firing patterns in response to LTDg 
stimulation (Lodge and Grace, 2006). The LTDg-VTA connection is an important connection 
that allows for the proper functioning of VTA dopamine neurons in response to rewarding 
situations (Yeomans et al, 2001; Lodge and Grace, 2006). No studies have stimulated the LTDg 
pharmacologically and investigated the resulting 50-kHz USVs vocalizations in rats.  
 The glutamatergic and cholinergic projection from the LTDg-VTA seems to be excitatory 
in both cases. However, electrophysiological recordings of dopamine neurons in aversive 
contexts show a sharp depression in dopamine firing patterns (Mileykovskiy and Morales, 2011; 
Mirenowicz and Schultaz, 1996). Thus activation of the LTDg under aversive contexts probably 
uses an indirect connection to inhibit the firing for dopamine neurons within the VTA. The 
lateral habenula (LH), a nucleus located within the epithalamus may be one such nucleus that 
relays negative values to the dopamine cells within the VTA.  
The habenula and the dorsal diencephalic conduction system 
 The LTDg has a strong reciprocal relationship with the LH (Cornwall et al, 1990) via the 
dorsal diencephalic condition system (DDC; Sutherland, 1982). The DDC system comprises the 
afferent system, the stria medullaris (sm), and its efferent system, the fasciculius retroflexus (fr; 
Brinschqitz et al, 2010). This DDC system is one of the main fiber systems that are used for 
communication between forebrain nuclei and catacholaminergic cell bodies located within the 
mesencephalon; this includes the VTA and the substantia nigra pars compacta. The medial root 
of the fr is composed of fibers from the medial habenula (MH) that terminate mainly on neurons 
localized within the interpeduncular nucleus, a prominent motor nucleus of the basal ganglia, in 
the rat (Hikosaka et al, 2008). The LH however is distinct from the MH in its fibers termination 
point. The LH does not primarily terminate on TH+ dopamine neurons in the VTA but rather 
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terminates with a large number of glutamatergic fibers on GAD positive neurons located in the 
rostromedial tegmental nucleus. (Hikosaka et al, 2008; Jt and Shperard, 2007; Matsumoto and 
Hikosaka, 2007). The rostromedial tegmental nucleus contains GABAergic neurons that project 
heavily to dopamine neurons located within the VTA. Essentially this connection allows the 
excitation of the LH neurons to excite GABA projection neurons in the rostromedial tegmental 
nucleus to release GABA, an inhibitory neurotransmitter onto dopamine neurons in the VTA 
causing them to hyperpolarize and decrease the release of dopamine along the mesolimbic 
dopamine system (Hong et al, 2011). This functionally antagonistic relationship is highlighted by 
metabolic, lesion and electrophysiological investigations.  
LH to VTA projection system: An antagonistic relationship 
 Metabolic studies have suggested an antagonistic relationship between the LH and the 
VTA. Systemic injections of dopamine agonists, such as R-(-)-apomorphine or d-amphetamine 
decrease 2-deoxyglucose (a measure of neuronal metabolic activity) utilization in the LH 
(Wechsler et al, 1979). Likewise injection of dopamine antagonists, such as haloperidol, 
increases the metabolic activity of the LH while decreasing the activity of the VTA and 
substantia niagra (McCulloch et al, 1980). The antagonistic relationship between the LH and the 
VTA was further supported by lesioning studies. 
 Injection of the dopaminergic neurotoxin, 6-hydroxydopamine, into the mesolimbic 
dopamine system, can increase the metabolic activity of the LH. Injections of TTX, a neurotoxin 
causing the cessation of neural activity, into the stria medullaris causes large increases in 
dopamine metabolism in the prefrontal cortex, olfactory tubercle and nucleus accumbens, as 
measured by levels of homovanilic acid (Nishikawa et al, 1986). Dopaminergic innervation of 
the prefrontal cortex, olfactory tubercle and nucleus accumbens comes from dopaminergic cell 
94 
 
bodies within the VTA. Further support that the LH mediates the decreased dopamine activity 
through the DDC comes from electrophysiological experiments.  
 If the dopamine neurons located within the VTA encode a reward or positive emotional 
state, and neurons in the LH encode a negative emotional state, then rewards should increase the 
activity of dopamine neurons in the VTA while inhibiting neurons in the LH. Conversely, 
noxious stimuli or the absence of reward should have opposing effects on the VTA and LH 
neuron activity causing LH neurons to depolarize (become active) and VTA neurons to 
hyperpolarize. Such a relationship was reported in monkeys by Matsumoto and Hikosaka (2007). 
Monkeys that were trained to respond to two types of visual cues, one visual cue that predicts a 
reward and one visual cue that predicts the absence of a reward, a paradigm that has been used to 
produce 50-kHz and 22-kHz USVs, respectively (Burgdorf, 2000). The results reported by 
Matsumoto and Hikosaka (2007) showed that the LH and the VTA have opposing firing activity. 
Visual cues that signal the presentation of a reward (juice) cause excitation in VTA neurons and 
an inhibition of LH neurons while visual cues that represent a negative, or punishing outcome (a 
jet of air aimed at the palm of the monkey) show excitation of the LH and inhibition of the VTA 
neurons (Matsumoto and Hikosaka, 2007). Similarly, Gao and colleagues (1996) reported that 
peripheral noxious stimulus (identified as a shock applied to the tail of the rat) increased the 
firing rate of LH neurons and inhibited substantia nigra pars compacta neurons (Gao et al, 1996). 
These results are congruent with Christoph and colleagues (1986) who reported stimulation of 
the LH in the rat causes an attenuation of 91% of dopamine-identified neurons within the VTA 
and 85% of dopamine-identified neurons within the substantia nigra pars compacta (Christoph et 
al, 1986).    
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 Despite the results suggesting a highly antagonistic relationship between the LH and the 
VTA, few studies have been done describing the relationship between the LTDg and the LH. 
Indirect Fos-immunoreactivity experiments investigating brain nuclei responsible for processing 
aversive stimuli show a consistent increase in Fos immunoreactive protein in both these brain 
structures (Martinez et al, 2002; Singewald et al, 2003). This is consistent with anatomical 
mapping studies showing that the LTDg and the LH have a strong reciprocal relationship 
(Herkenham and Nauta, 1977). Despite this anatomical connection, and the involvement of these 
nuclei during punishing and negative emotional-arousing situations, their electrophysiological 
relationship remains to be investigated.  
 Indirect evidence of a functional relationship between the LH and the LTDg can be 
observed using Fos-immunoreactivity. Both the LH and the LTDg show increased activity 
during the production of 22-kHz USVs or during the playback of 22-kHz USVs. Brudzynski and 
colleagues showed doubled labeled cholinergic cells in the LTDg in response to carbachol 
induced 22-kHz USVs from the AH-MPO (Brudzynski, 2011). Playback studies using 22-kHz 
USVs show increased Fos-immunoreactivity within the main input nucleus of the habenula 
complex (Beckett et al, 1997) and LTDg (Sadananda et al, 2008) supporting the hypothesis of a 
functional relationship between the LTDg and the LH during aversive situations. 
LTDg-LH-VTA connection during negative emotional processing 
 If a functional relationship between the LTDg-LH-VTA exists, it would allow the 
ascending mesolimbic cholinergic system to use the LH to shut down activity of the ascending 
mesolimbic dopamine system during aversive situations. Such a relationship does explain why 
activation of the mesolimbic cholinergic system, by carbachol injections into the LH or the AH-
MPO, was able to decrease the number of apomorphine emitted 50-kHz USVs. Further 
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electrophysiological, immunohistochemical and behavioural investigations will need to be 
conducted to establish that such a relationship exists in the rat during the production of aversive 
USVs. 
VTA-LH-LTDg connection during positive emotional processing 
 Anticipation of rewards increases the activity of dopamine neurons within the VTA 
(Mirenowicz and Schultz, 1996), increase dopamine efflux in the shell of the nucleus accumbens 
(Knuston et al, 2001), and inhibits the firing of LH neurons (Mirenowicz and Schultz, 1996). 
Electrophysiological experiments show that the connections between the VTA and the LH are 
antagonistic since electrical stimulation of the VTA is able to cause a current-dependent 
inhibition of 90% of aversion-related LH neurons (Shen et al, 2012). Although the authors did 
not do any pharmacological analysis of the transmitter’s involved VTA-LH connection, in situ 
hybridization studies have reported D2 mRNA localized within the LH (Brouwer et al, 1992). 
Since D2 receptors are linked to increases in potassium-related currents (Vallar & Meldolesi, 
1989), which suppresses neuronal activity of a neuron by hypopolarizing the cell, this could 
explain the reported inhibition of LH neurons by VTA activity. Another mechanism could be 
reward related signals projected from the edge cells onto LH neurons, but this functional link has 
only been described in primates (Hong & Hikosaka, 2008). Since the edge cells are localized 
within the internal globus pallidus in primates, a similar function connection would have to exist 
within the entopeduncular nucleus of the rat, since this is the homolog to the internal division of 
the globus pallidus in primates. Such connects have been reported (Kooey and Carter, 1981) but 
a functional relationship has yet to be established.  
 To explain the decreased production of carbachol-induced 22-kHz USVs by prior 
activation of the mesolimbic dopamine system, a direct antagonist relationship would also have 
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to exist between the LH and the LTDg whereby inhibition of the LH would cause an inhibition 
of neurons within the LTDg. Such a functional relationship has not been reported.  Further 
investigation of the LH during 50- and 22-kHz USVs would be needed to confirm the operation 
of such a circuit between the LH and LTDg. Although the central question of the thesis was 
answered, the mechanisms remain elusive.  
Evaluation of Question 4 
 Mean call duration and mean peak-frequency values were used to characterize the 
acoustic features recorded USVs. The mean value of all obtained 50-kHz USVs in this thesis fell 
within acceptable ranges of 50-kHz USVs reported within the literature (Brudzynski, 2009, 
Burgdorf, 2000). Peak-frequency of the vocalizations fell between 38-90 kHz and the duration of 
the recorded 50-kHz fell between 10-80 ms. Under no experimental conditions did the peak 
frequency or the duration of 50-kHz USVs change. This suggests that duration and peak-
frequency of 50-kHz USVs may be needed to convey appetitive information. This was consistent 
with the prediction.  
 The mean values of all obtained 22-kHz USVs in this thesis also fell within the reported 
ranges of 22-kHz USVs (Bihari et al, 2003). These recorded USVs had a peak frequency of 19-
29 kHz and duration between 100 – 3000 ms. As reported in the results section, the duration of 
22-kHz USVs under all conditions were significantly reduced with activation of the mesolimbic 
dopamine system. This was not consistent with the fourth prediction. The consistent decrease in 
the duration of recorded 22-kHz USVs may signal the degree of anxiety in the sender; the shorter 
the 22-kHz USVs the less anxiety the animal is conveying. Playback studies using 22-kHz USVs 
of varying duration will be able to support or refute such a conclusion. 
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 Localization of injection sites 
 Localization of injections for the dose-response study, as well as the double-injection 
groups for the nucleus accumbens, were found between 10.6 mm – 9.7 mm, laterally from 0.7 – 
1.3 mm from the midline making the resulting injections span across the core and shell of the 
nucleus accumbens. Analysis of the magnitude of pharmacologically-induced 50-kHz USVs in 
the nucleus accumbens showed that the highest sensitivity to apomorphine was found within the 
medial shell of the nucleus accumbens and decreased laterally across the shell. The core of the 
nucleus accumbens, which is related to the motor system (Zahm & Brog, 1992), produced 
substantially lower 50-kHz USVs when compared to shell. The ability of the core to produce a 
low-level of 50-kHz USVs is likely due to diffusion of the drug out of the core and onto the 
medial border of the shell. Injection into pallidum, fiber tracts, or ventricles failed to produce any 
50-kHz USVs.  
 Localization of injections for the AH-MPO and the LS were in accordance with injection 
sites reported in the literature to produce 22-kHz USVs (Bihari et al, 2003; Brudzynski, 2011). 
Injections into the ventricles, or fiber tracts were unable to produce any 22-kHz USVs. 
Future research 
 
Future research stems from three perspectives. The first is the pharmacological action of 
carbachol which is a broad spectrum muscarinic agonist with some affinity for nicotinic 
receptors. Since muscarinic and nicotinic receptors are expressed within the AH-MPO and the 
LS, it would be of importance to tease out whether selective muscarinic or nicotic or both 
receptors are involved in the expression of aversive states in rats. The second perspective is the 
functional relationship between the LTDg and the LH. It would be interesting to record the 
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responses of the LH neurons to application of glutamate into the LTDg, an injection condition 
that is known to produce the emission of 22-kHz USVs, this would provide direct evidence of 
the relationship between these two structures during the production of 22-kHz USVs. The third 
perspective is viewing the LTDg as a station that can toggle mesencephalic nuclei for the 
initiation of different emotional states. Since the LTDg is a primarily cholinergic structure, it 
would have to contain two or more distinct populations of cholinergic neurons. One group of 
these cholinergic cell bodies would interact with the ascending mesolimbic dopamine system 
during appetitive circumstances. The second cluster of cholinergic neurons would be responsible 
for releasing acetylcholine into the terminal fields of the mesolimbic cholinergic system and 
subsequently activating the LH to inhibit the dopamine containing cell bodies within the VTA. 
The activity of the two different clusters of cholinergic cells would be toggled by activation of 
different GABAergic interneurons that receive excitatory glutamatergic input from multiple 
limbic brain structures along the neuraxis. Interestingly, the LTDg expresses mRNA for glutamic 
acid decarboxylase (GAD), a cellular marker for GABAergic releasing neurons, in about 5% of 
cells (Wang & Morales, 2009). It would be interesting if this small cluster of GABAergic cells 
functioned in the a similar, yet opposing, manner as the small cluster of GABAergic cells located 
within the rostromedial tegmental nucleus that are activated in negative emotional situations to 
inhibit dopamine cell bodies within the VTA. This would provide a mechanism to inhibit the 
LTDg during appetitive states by activation of these GABAergic cells, which would inhibit 
acetylcholine release from the LTDg into the medial cholinoceptive vocalization strip.  
Conclusions 
The central question that this thesis focused on was if the systems governing the 
expression of emotional states in rats interact, and what is the relationship of this interaction. 
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Activation of the mesolimbic dopamine system, prior to activation of the ascending mesolimbic 
cholinergic system, was able to decrease the number of aversive 22-kHz USVs while activation 
of the mesolimbic cholinergic system, prior to activation of the ascending mesolimbic dopamine 
system, was able to decrease the number of 50-kHz USVs. The decrease in 22-kHz and 50-kHz 
USVs indexed a selective decrease in an appetitive state or an aversive state. The central 
question was answered. It can be concluded that the neural systems responsible for aversive and 
appetitive USVs interact, and that the nature of this interaction is antagonistic.     
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